Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MEIS2
|
ENSG00000134138.15 | Meis homeobox 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MEIS2 | hg19_v2_chr15_-_37390482_37390572 | -0.87 | 1.4e-10 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr6_-_133084580 | 5.57 |
ENST00000525270.1
ENST00000530536.1 ENST00000524919.1 |
VNN2
|
vanin 2 |
chr7_+_37723450 | 4.95 |
ENST00000447769.1
|
GPR141
|
G protein-coupled receptor 141 |
chr17_-_29648761 | 4.86 |
ENST00000247270.3
ENST00000462804.2 |
EVI2A
|
ecotropic viral integration site 2A |
chr6_-_133084564 | 4.79 |
ENST00000532012.1
|
VNN2
|
vanin 2 |
chr1_-_167487758 | 4.64 |
ENST00000362089.5
|
CD247
|
CD247 molecule |
chr8_-_126963387 | 4.52 |
ENST00000522865.1
ENST00000517869.1 |
LINC00861
|
long intergenic non-protein coding RNA 861 |
chr7_-_142162390 | 4.37 |
ENST00000390371.3
|
TRBV6-6
|
T cell receptor beta variable 6-6 |
chr7_-_142224280 | 4.29 |
ENST00000390367.3
|
TRBV11-1
|
T cell receptor beta variable 11-1 |
chr6_+_42883727 | 4.24 |
ENST00000304672.1
ENST00000441198.1 ENST00000446507.1 |
PTCRA
|
pre T-cell antigen receptor alpha |
chr2_+_204801471 | 4.19 |
ENST00000316386.6
ENST00000435193.1 |
ICOS
|
inducible T-cell co-stimulator |
chr1_-_27961720 | 4.15 |
ENST00000545953.1
ENST00000374005.3 |
FGR
|
feline Gardner-Rasheed sarcoma viral oncogene homolog |
chr14_+_22631122 | 4.13 |
ENST00000390458.3
|
TRAV29DV5
|
T cell receptor alpha variable 29/delta variable 5 (gene/pseudogene) |
chr15_+_81589254 | 4.09 |
ENST00000394652.2
|
IL16
|
interleukin 16 |
chr1_+_158900568 | 4.09 |
ENST00000458222.1
|
PYHIN1
|
pyrin and HIN domain family, member 1 |
chr6_+_53948328 | 4.08 |
ENST00000370876.2
|
MLIP
|
muscular LMNA-interacting protein |
chr7_-_38339890 | 3.99 |
ENST00000390341.2
|
TRGV10
|
T cell receptor gamma variable 10 (non-functional) |
chr8_-_126963487 | 3.93 |
ENST00000518964.1
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
chrX_+_135730297 | 3.93 |
ENST00000370629.2
|
CD40LG
|
CD40 ligand |
chr3_-_112218378 | 3.92 |
ENST00000334529.5
|
BTLA
|
B and T lymphocyte associated |
chr8_-_126963417 | 3.85 |
ENST00000500989.2
|
LINC00861
|
long intergenic non-protein coding RNA 861 |
chr13_+_32313658 | 3.85 |
ENST00000380314.1
ENST00000298386.2 |
RXFP2
|
relaxin/insulin-like family peptide receptor 2 |
chr13_-_46716969 | 3.80 |
ENST00000435666.2
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr14_+_22554680 | 3.76 |
ENST00000390451.2
|
TRAV23DV6
|
T cell receptor alpha variable 23/delta variable 6 |
chr16_+_30484021 | 3.76 |
ENST00000358164.5
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr1_-_160832670 | 3.74 |
ENST00000368032.2
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chr4_-_70653673 | 3.73 |
ENST00000512870.1
|
SULT1B1
|
sulfotransferase family, cytosolic, 1B, member 1 |
chr7_+_37723336 | 3.73 |
ENST00000450180.1
|
GPR141
|
G protein-coupled receptor 141 |
chr14_+_22675388 | 3.66 |
ENST00000390461.2
|
TRAV34
|
T cell receptor alpha variable 34 |
chr1_-_160832490 | 3.62 |
ENST00000322302.7
ENST00000368033.3 |
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chrX_+_135730373 | 3.61 |
ENST00000370628.2
|
CD40LG
|
CD40 ligand |
chr8_-_134114866 | 3.57 |
ENST00000524345.1
|
SLA
|
Src-like-adaptor |
chr14_+_22580233 | 3.56 |
ENST00000390454.2
|
TRAV25
|
T cell receptor alpha variable 25 |
chr7_+_142028105 | 3.56 |
ENST00000390353.2
|
TRBV6-1
|
T cell receptor beta variable 6-1 |
chr19_+_55085248 | 3.56 |
ENST00000391738.3
ENST00000251376.3 ENST00000391737.1 ENST00000396321.2 ENST00000418536.2 ENST00000448689.1 |
LILRA2
LILRB1
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 |
chr16_+_30483962 | 3.54 |
ENST00000356798.6
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr7_-_142139783 | 3.47 |
ENST00000390374.3
|
TRBV7-6
|
T cell receptor beta variable 7-6 |
chr16_+_27413483 | 3.45 |
ENST00000337929.3
ENST00000564089.1 |
IL21R
|
interleukin 21 receptor |
chr11_-_2323089 | 3.38 |
ENST00000456145.2
|
C11orf21
|
chromosome 11 open reading frame 21 |
chr19_-_51875894 | 3.38 |
ENST00000600427.1
ENST00000595217.1 ENST00000221978.5 |
NKG7
|
natural killer cell group 7 sequence |
chr7_-_142207004 | 3.38 |
ENST00000426318.2
|
TRBV10-2
|
T cell receptor beta variable 10-2 |
chr16_+_30484054 | 3.36 |
ENST00000564118.1
ENST00000454514.2 ENST00000433423.2 |
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr7_-_142511084 | 3.30 |
ENST00000417977.2
|
TRBV30
|
T cell receptor beta variable 30 (gene/pseudogene) |
chr1_-_183538319 | 3.27 |
ENST00000420553.1
ENST00000419402.1 |
NCF2
|
neutrophil cytosolic factor 2 |
chr5_+_35852797 | 3.23 |
ENST00000508941.1
|
IL7R
|
interleukin 7 receptor |
chr7_-_29235063 | 3.22 |
ENST00000437527.1
ENST00000455544.1 |
CPVL
|
carboxypeptidase, vitellogenic-like |
chr1_+_66458072 | 3.21 |
ENST00000423207.2
|
PDE4B
|
phosphodiesterase 4B, cAMP-specific |
chr1_-_159684371 | 3.21 |
ENST00000255030.5
ENST00000437342.1 ENST00000368112.1 ENST00000368111.1 ENST00000368110.1 ENST00000343919.2 |
CRP
|
C-reactive protein, pentraxin-related |
chr19_-_54784353 | 3.19 |
ENST00000391746.1
|
LILRB2
|
leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2 |
chr13_-_46785977 | 3.18 |
ENST00000442275.1
|
LCP1
|
lymphocyte cytosolic protein 1 (L-plastin) |
chr6_-_108145499 | 3.15 |
ENST00000369020.3
ENST00000369022.2 |
SCML4
|
sex comb on midleg-like 4 (Drosophila) |
chr6_-_24936170 | 3.14 |
ENST00000538035.1
|
FAM65B
|
family with sequence similarity 65, member B |
chr3_-_44465475 | 3.13 |
ENST00000416124.1
|
LINC00694
|
long intergenic non-protein coding RNA 694 |
chr1_-_160832642 | 3.13 |
ENST00000368034.4
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4 |
chr12_-_109027643 | 3.08 |
ENST00000388962.3
ENST00000550948.1 |
SELPLG
|
selectin P ligand |
chr8_-_134114721 | 3.03 |
ENST00000522119.1
ENST00000523610.1 ENST00000521302.1 ENST00000519558.1 ENST00000519747.1 ENST00000517648.1 |
SLA
|
Src-like-adaptor |
chr1_-_161600942 | 2.98 |
ENST00000421702.2
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chrX_-_70331298 | 2.97 |
ENST00000456850.2
ENST00000473378.1 ENST00000487883.1 ENST00000374202.2 |
IL2RG
|
interleukin 2 receptor, gamma |
chrX_-_47489244 | 2.97 |
ENST00000469388.1
ENST00000396992.3 ENST00000377005.2 |
CFP
|
complement factor properdin |
chr4_-_74847800 | 2.96 |
ENST00000296029.3
|
PF4
|
platelet factor 4 |
chr14_+_22739823 | 2.93 |
ENST00000390464.2
|
TRAV38-1
|
T cell receptor alpha variable 38-1 |
chr19_-_51875523 | 2.91 |
ENST00000593572.1
ENST00000595157.1 |
NKG7
|
natural killer cell group 7 sequence |
chr12_-_10562356 | 2.90 |
ENST00000309384.1
|
KLRC4
|
killer cell lectin-like receptor subfamily C, member 4 |
chr4_-_48116540 | 2.88 |
ENST00000506073.1
|
TXK
|
TXK tyrosine kinase |
chr1_+_161185032 | 2.87 |
ENST00000367992.3
ENST00000289902.1 |
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide |
chr8_-_133772870 | 2.87 |
ENST00000522334.1
ENST00000519016.1 |
TMEM71
|
transmembrane protein 71 |
chr13_-_99959641 | 2.84 |
ENST00000376414.4
|
GPR183
|
G protein-coupled receptor 183 |
chr19_-_54604083 | 2.83 |
ENST00000391761.1
ENST00000356532.3 ENST00000359649.4 ENST00000358375.4 ENST00000391760.1 ENST00000351806.4 |
OSCAR
|
osteoclast associated, immunoglobulin-like receptor |
chr2_-_87018784 | 2.83 |
ENST00000283635.3
ENST00000538832.1 |
CD8A
|
CD8a molecule |
chr3_-_72150076 | 2.81 |
ENST00000488545.1
ENST00000608654.1 |
LINC00877
|
long intergenic non-protein coding RNA 877 |
chr5_+_112074029 | 2.79 |
ENST00000512211.2
|
APC
|
adenomatous polyposis coli |
chr19_+_14693888 | 2.77 |
ENST00000547437.1
ENST00000397439.2 ENST00000417570.1 |
CLEC17A
|
C-type lectin domain family 17, member A |
chr19_+_51628165 | 2.75 |
ENST00000250360.3
ENST00000440804.3 |
SIGLEC9
|
sialic acid binding Ig-like lectin 9 |
chr7_+_142008340 | 2.74 |
ENST00000390387.3
|
TRBV3-1
|
T cell receptor beta variable 3-1 |
chr14_+_23002427 | 2.72 |
ENST00000390527.1
|
TRAJ10
|
T cell receptor alpha joining 10 |
chr8_+_31497271 | 2.72 |
ENST00000520407.1
|
NRG1
|
neuregulin 1 |
chr14_+_22670455 | 2.72 |
ENST00000390460.1
|
TRAV26-2
|
T cell receptor alpha variable 26-2 |
chr1_-_161600990 | 2.68 |
ENST00000531221.1
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) |
chr17_-_47286729 | 2.65 |
ENST00000300406.2
ENST00000511277.1 ENST00000511673.1 |
GNGT2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr5_-_169694286 | 2.65 |
ENST00000521416.1
ENST00000520344.1 |
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr7_+_142045246 | 2.64 |
ENST00000390392.3
|
TRBV4-2
|
T cell receptor beta variable 4-2 |
chr7_+_142020496 | 2.63 |
ENST00000390381.3
|
TRBV5-1
|
T cell receptor beta variable 5-1 |
chr2_-_32489922 | 2.63 |
ENST00000402280.1
|
NLRC4
|
NLR family, CARD domain containing 4 |
chr3_+_111260980 | 2.63 |
ENST00000438817.2
|
CD96
|
CD96 molecule |
chr17_-_72527605 | 2.61 |
ENST00000392621.1
ENST00000314401.3 |
CD300LB
|
CD300 molecule-like family member b |
chr4_+_40198527 | 2.61 |
ENST00000381799.5
|
RHOH
|
ras homolog family member H |
chr1_-_207096529 | 2.60 |
ENST00000525793.1
ENST00000529560.1 |
FAIM3
|
Fas apoptotic inhibitory molecule 3 |
chr12_+_9144626 | 2.60 |
ENST00000543895.1
|
KLRG1
|
killer cell lectin-like receptor subfamily G, member 1 |
chr14_-_23877474 | 2.59 |
ENST00000405093.3
|
MYH6
|
myosin, heavy chain 6, cardiac muscle, alpha |
chr4_-_165305086 | 2.59 |
ENST00000507270.1
ENST00000514618.1 ENST00000503008.1 |
MARCH1
|
membrane-associated ring finger (C3HC4) 1, E3 ubiquitin protein ligase |
chr5_-_169725231 | 2.58 |
ENST00000046794.5
|
LCP2
|
lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) |
chr21_+_30503282 | 2.58 |
ENST00000399925.1
|
MAP3K7CL
|
MAP3K7 C-terminal like |
chr6_-_159466136 | 2.57 |
ENST00000367066.3
ENST00000326965.6 |
TAGAP
|
T-cell activation RhoGTPase activating protein |
chr19_+_51645556 | 2.55 |
ENST00000601682.1
ENST00000317643.6 ENST00000305628.7 ENST00000600577.1 |
SIGLEC7
|
sialic acid binding Ig-like lectin 7 |
chr19_+_42300369 | 2.55 |
ENST00000357396.3
ENST00000221999.4 |
CEACAM3
|
carcinoembryonic antigen-related cell adhesion molecule 3 |
chr7_+_142448053 | 2.54 |
ENST00000422143.2
|
TRBV29-1
|
T cell receptor beta variable 29-1 |
chr2_-_179672142 | 2.52 |
ENST00000342992.6
ENST00000360870.5 ENST00000460472.2 ENST00000589042.1 ENST00000591111.1 ENST00000342175.6 ENST00000359218.5 |
TTN
|
titin |
chr11_+_118175132 | 2.51 |
ENST00000361763.4
|
CD3E
|
CD3e molecule, epsilon (CD3-TCR complex) |
chr16_+_30194293 | 2.51 |
ENST00000561815.1
|
CORO1A
|
coronin, actin binding protein, 1A |
chr14_+_23016437 | 2.50 |
ENST00000478163.3
|
TRAC
|
T cell receptor alpha constant |
chr19_-_3801789 | 2.49 |
ENST00000590849.1
ENST00000395045.2 |
MATK
|
megakaryocyte-associated tyrosine kinase |
chr1_-_153363452 | 2.47 |
ENST00000368732.1
ENST00000368733.3 |
S100A8
|
S100 calcium binding protein A8 |
chr10_+_129785574 | 2.47 |
ENST00000430713.2
ENST00000471218.1 |
PTPRE
|
protein tyrosine phosphatase, receptor type, E |
chr12_-_111358372 | 2.47 |
ENST00000548438.1
ENST00000228841.8 |
MYL2
|
myosin, light chain 2, regulatory, cardiac, slow |
chr1_-_161600822 | 2.45 |
ENST00000534776.1
ENST00000540048.1 |
FCGR3B
FCGR3A
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr14_-_106471723 | 2.43 |
ENST00000390595.2
|
IGHV1-3
|
immunoglobulin heavy variable 1-3 |
chr6_-_130182410 | 2.42 |
ENST00000368143.1
|
TMEM244
|
transmembrane protein 244 |
chr12_+_8662057 | 2.41 |
ENST00000382064.2
|
CLEC4D
|
C-type lectin domain family 4, member D |
chr6_+_53948221 | 2.40 |
ENST00000460844.2
|
MLIP
|
muscular LMNA-interacting protein |
chr11_-_2323290 | 2.40 |
ENST00000381153.3
|
C11orf21
|
chromosome 11 open reading frame 21 |
chr17_+_16318909 | 2.39 |
ENST00000577397.1
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr17_+_45810594 | 2.37 |
ENST00000177694.1
|
TBX21
|
T-box 21 |
chr17_-_38020392 | 2.37 |
ENST00000346872.3
ENST00000439167.2 ENST00000377945.3 ENST00000394189.2 ENST00000377944.3 ENST00000377958.2 ENST00000535189.1 ENST00000377952.2 |
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
chr10_+_129785536 | 2.36 |
ENST00000419012.2
|
PTPRE
|
protein tyrosine phosphatase, receptor type, E |
chr8_-_134115118 | 2.36 |
ENST00000395352.3
ENST00000338087.5 |
SLA
|
Src-like-adaptor |
chr7_+_142031986 | 2.36 |
ENST00000547918.2
|
TRBV7-1
|
T cell receptor beta variable 7-1 (non-functional) |
chr7_+_80267973 | 2.35 |
ENST00000394788.3
ENST00000447544.2 |
CD36
|
CD36 molecule (thrombospondin receptor) |
chr6_+_31674639 | 2.35 |
ENST00000556581.1
ENST00000375832.4 ENST00000503322.1 |
LY6G6F
MEGT1
|
lymphocyte antigen 6 complex, locus G6F HCG43720, isoform CRA_a; Lymphocyte antigen 6 complex locus protein G6f; Megakaryocyte-enhanced gene transcript 1 protein; Uncharacterized protein |
chr7_-_142169013 | 2.35 |
ENST00000454561.2
|
TRBV5-4
|
T cell receptor beta variable 5-4 |
chr19_+_52264104 | 2.34 |
ENST00000340023.6
|
FPR2
|
formyl peptide receptor 2 |
chr8_+_27184320 | 2.32 |
ENST00000522517.1
|
PTK2B
|
protein tyrosine kinase 2 beta |
chr14_+_22748980 | 2.32 |
ENST00000390465.2
|
TRAV38-2DV8
|
T cell receptor alpha variable 38-2/delta variable 8 |
chr7_-_38389573 | 2.32 |
ENST00000390344.2
|
TRGV5
|
T cell receptor gamma variable 5 |
chr8_-_134114887 | 2.31 |
ENST00000519341.1
|
SLA
|
Src-like-adaptor |
chr1_+_174933899 | 2.31 |
ENST00000367688.3
|
RABGAP1L
|
RAB GTPase activating protein 1-like |
chrX_+_78426469 | 2.30 |
ENST00000276077.1
|
GPR174
|
G protein-coupled receptor 174 |
chr6_-_41122063 | 2.30 |
ENST00000426005.2
ENST00000437044.2 ENST00000373127.4 |
TREML1
|
triggering receptor expressed on myeloid cells-like 1 |
chr19_-_52254050 | 2.30 |
ENST00000600815.1
|
FPR1
|
formyl peptide receptor 1 |
chr17_+_16318850 | 2.30 |
ENST00000338560.7
|
TRPV2
|
transient receptor potential cation channel, subfamily V, member 2 |
chr1_+_159772121 | 2.29 |
ENST00000339348.5
ENST00000392235.3 ENST00000368106.3 |
FCRL6
|
Fc receptor-like 6 |
chr14_+_22471345 | 2.29 |
ENST00000390446.3
|
TRAV18
|
T cell receptor alpha variable 18 |
chr2_-_8464760 | 2.28 |
ENST00000430192.1
|
LINC00299
|
long intergenic non-protein coding RNA 299 |
chr2_+_74229812 | 2.27 |
ENST00000305799.7
|
TET3
|
tet methylcytosine dioxygenase 3 |
chr16_+_30194916 | 2.25 |
ENST00000570045.1
ENST00000565497.1 ENST00000570244.1 |
CORO1A
|
coronin, actin binding protein, 1A |
chr17_-_38020379 | 2.23 |
ENST00000351680.3
ENST00000346243.3 ENST00000350532.3 ENST00000467757.1 ENST00000439016.2 |
IKZF3
|
IKAROS family zinc finger 3 (Aiolos) |
chr6_-_31560729 | 2.22 |
ENST00000340027.5
ENST00000376073.4 ENST00000376072.3 |
NCR3
|
natural cytotoxicity triggering receptor 3 |
chr2_-_87017948 | 2.22 |
ENST00000409781.1
|
CD8A
|
CD8a molecule |
chr7_-_38289173 | 2.21 |
ENST00000436911.2
|
TRGC2
|
T cell receptor gamma constant 2 |
chr14_+_22236722 | 2.21 |
ENST00000390428.3
|
TRAV6
|
T cell receptor alpha variable 6 |
chr9_-_137809718 | 2.21 |
ENST00000371806.3
|
FCN1
|
ficolin (collagen/fibrinogen domain containing) 1 |
chr11_+_60869867 | 2.21 |
ENST00000347785.3
|
CD5
|
CD5 molecule |
chr1_+_153330322 | 2.20 |
ENST00000368738.3
|
S100A9
|
S100 calcium binding protein A9 |
chr5_+_39105358 | 2.20 |
ENST00000593965.1
|
AC008964.1
|
AC008964.1 |
chr22_+_42148515 | 2.20 |
ENST00000540880.1
|
MEI1
|
meiosis inhibitor 1 |
chr14_+_22392209 | 2.20 |
ENST00000390440.2
|
TRAV14DV4
|
T cell receptor alpha variable 14/delta variable 4 |
chr3_-_27763803 | 2.20 |
ENST00000449599.1
|
EOMES
|
eomesodermin |
chr7_+_18330035 | 2.19 |
ENST00000413509.2
|
HDAC9
|
histone deacetylase 9 |
chr14_+_22446680 | 2.19 |
ENST00000390443.3
|
TRAV8-6
|
T cell receptor alpha variable 8-6 |
chr2_-_113594279 | 2.19 |
ENST00000416750.1
ENST00000418817.1 ENST00000263341.2 |
IL1B
|
interleukin 1, beta |
chr19_-_52150053 | 2.17 |
ENST00000599649.1
ENST00000429354.3 ENST00000360844.6 ENST00000222107.4 |
SIGLEC5
SIGLEC14
SIGLEC5
|
SIGLEC5 sialic acid binding Ig-like lectin 14 sialic acid binding Ig-like lectin 5 |
chr11_+_122733011 | 2.16 |
ENST00000533709.1
|
CRTAM
|
cytotoxic and regulatory T cell molecule |
chr21_+_43823983 | 2.15 |
ENST00000291535.6
ENST00000450356.1 ENST00000319294.6 ENST00000398367.1 |
UBASH3A
|
ubiquitin associated and SH3 domain containing A |
chr21_+_30502806 | 2.15 |
ENST00000399928.1
ENST00000399926.1 |
MAP3K7CL
|
MAP3K7 C-terminal like |
chr11_+_12132117 | 2.14 |
ENST00000256194.4
|
MICAL2
|
microtubule associated monooxygenase, calponin and LIM domain containing 2 |
chr1_+_27158505 | 2.14 |
ENST00000534643.1
|
ZDHHC18
|
zinc finger, DHHC-type containing 18 |
chr14_+_22615942 | 2.14 |
ENST00000390457.2
|
TRAV27
|
T cell receptor alpha variable 27 |
chr6_-_24911195 | 2.13 |
ENST00000259698.4
|
FAM65B
|
family with sequence similarity 65, member B |
chr9_-_136004782 | 2.11 |
ENST00000393157.3
|
RALGDS
|
ral guanine nucleotide dissociation stimulator |
chr14_-_106312010 | 2.11 |
ENST00000390556.2
|
IGHD
|
immunoglobulin heavy constant delta |
chr17_-_47286579 | 2.10 |
ENST00000515635.1
|
GNGT2
|
guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 |
chr22_-_30661807 | 2.10 |
ENST00000403389.1
|
OSM
|
oncostatin M |
chr16_+_57702210 | 2.10 |
ENST00000450388.3
|
GPR97
|
G protein-coupled receptor 97 |
chr1_+_158815588 | 2.09 |
ENST00000438394.1
|
MNDA
|
myeloid cell nuclear differentiation antigen |
chrX_+_12885183 | 2.09 |
ENST00000380659.3
|
TLR7
|
toll-like receptor 7 |
chr6_-_113953705 | 2.09 |
ENST00000452675.1
|
RP11-367G18.1
|
RP11-367G18.1 |
chr3_+_111260856 | 2.08 |
ENST00000352690.4
|
CD96
|
CD96 molecule |
chr17_+_44803922 | 2.08 |
ENST00000465370.1
|
NSF
|
N-ethylmaleimide-sensitive factor |
chr4_-_130014532 | 2.08 |
ENST00000506368.1
ENST00000439369.2 ENST00000503215.1 |
SCLT1
|
sodium channel and clathrin linker 1 |
chr6_+_106546808 | 2.08 |
ENST00000369089.3
|
PRDM1
|
PR domain containing 1, with ZNF domain |
chr17_-_7081435 | 2.08 |
ENST00000380920.4
|
ASGR1
|
asialoglycoprotein receptor 1 |
chr3_+_108541545 | 2.08 |
ENST00000295756.6
|
TRAT1
|
T cell receptor associated transmembrane adaptor 1 |
chr10_+_49892904 | 2.07 |
ENST00000360890.2
|
WDFY4
|
WDFY family member 4 |
chr19_-_48547294 | 2.07 |
ENST00000293255.2
|
CABP5
|
calcium binding protein 5 |
chr5_+_54320078 | 2.07 |
ENST00000231009.2
|
GZMK
|
granzyme K (granzyme 3; tryptase II) |
chr1_+_154293584 | 2.06 |
ENST00000324978.3
ENST00000484864.1 |
AQP10
|
aquaporin 10 |
chr11_-_1782625 | 2.06 |
ENST00000438213.1
|
CTSD
|
cathepsin D |
chr8_-_6836156 | 2.06 |
ENST00000382679.2
|
DEFA1
|
defensin, alpha 1 |
chr16_+_5009250 | 2.06 |
ENST00000587469.1
|
SEC14L5
|
SEC14-like 5 (S. cerevisiae) |
chr16_-_55478666 | 2.05 |
ENST00000565307.1
|
RP11-212I21.2
|
RP11-212I21.2 |
chr2_-_87017985 | 2.05 |
ENST00000352580.3
|
CD8A
|
CD8a molecule |
chr7_-_142247606 | 2.04 |
ENST00000390361.3
|
TRBV7-3
|
T cell receptor beta variable 7-3 |
chr14_+_22978168 | 2.04 |
ENST00000390505.1
|
TRAJ32
|
T cell receptor alpha joining 32 |
chr6_+_32407619 | 2.04 |
ENST00000395388.2
ENST00000374982.5 |
HLA-DRA
|
major histocompatibility complex, class II, DR alpha |
chr14_+_22591276 | 2.04 |
ENST00000390455.3
|
TRAV26-1
|
T cell receptor alpha variable 26-1 |
chr7_-_142120321 | 2.03 |
ENST00000390377.1
|
TRBV7-7
|
T cell receptor beta variable 7-7 |
chr16_+_56782118 | 2.03 |
ENST00000566678.1
|
NUP93
|
nucleoporin 93kDa |
chr19_+_35939154 | 2.02 |
ENST00000599180.2
|
FFAR2
|
free fatty acid receptor 2 |
chr3_+_111260954 | 2.02 |
ENST00000283285.5
|
CD96
|
CD96 molecule |
chr11_+_60869980 | 2.02 |
ENST00000544014.1
|
CD5
|
CD5 molecule |
chr11_+_60223312 | 2.02 |
ENST00000532491.1
ENST00000532073.1 ENST00000534668.1 ENST00000528313.1 ENST00000533306.1 |
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1 |
chr16_+_58033450 | 2.01 |
ENST00000561743.1
|
USB1
|
U6 snRNA biogenesis 1 |
chr10_-_72362515 | 2.00 |
ENST00000373209.2
ENST00000441259.1 |
PRF1
|
perforin 1 (pore forming protein) |
chr6_+_41021027 | 2.00 |
ENST00000244669.2
|
APOBEC2
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 |
chr19_-_54804173 | 2.00 |
ENST00000391744.3
ENST00000251390.3 |
LILRA3
|
leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 |
chr1_-_161519682 | 1.99 |
ENST00000367969.3
ENST00000443193.1 |
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a) |
chr17_-_38721711 | 1.99 |
ENST00000578085.1
ENST00000246657.2 |
CCR7
|
chemokine (C-C motif) receptor 7 |
chr15_-_22448819 | 1.99 |
ENST00000604066.1
|
IGHV1OR15-1
|
immunoglobulin heavy variable 1/OR15-1 (non-functional) |
chr1_+_40862501 | 1.98 |
ENST00000539317.1
|
SMAP2
|
small ArfGAP2 |
chrX_+_71353499 | 1.98 |
ENST00000373677.1
|
NHSL2
|
NHS-like 2 |
chr16_-_50715239 | 1.97 |
ENST00000330943.4
ENST00000300590.3 |
SNX20
|
sorting nexin 20 |
chr1_+_159770292 | 1.97 |
ENST00000536257.1
ENST00000321935.6 |
FCRL6
|
Fc receptor-like 6 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 11.9 | GO:0071613 | granzyme B production(GO:0071613) regulation of granzyme B production(GO:0071661) positive regulation of granzyme B production(GO:0071663) |
2.2 | 6.7 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
1.6 | 4.7 | GO:0001812 | positive regulation of type I hypersensitivity(GO:0001812) |
1.5 | 4.5 | GO:1990108 | protein linear deubiquitination(GO:1990108) |
1.5 | 5.9 | GO:2001191 | gamma-delta T cell activation involved in immune response(GO:0002290) negative regulation of interferon-beta secretion(GO:0035548) regulation of gamma-delta T cell activation involved in immune response(GO:2001191) positive regulation of gamma-delta T cell activation involved in immune response(GO:2001193) |
1.4 | 7.2 | GO:0032796 | uropod organization(GO:0032796) |
1.4 | 7.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
1.4 | 4.2 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.4 | 2.7 | GO:0002503 | peptide antigen assembly with MHC class II protein complex(GO:0002503) |
1.3 | 4.0 | GO:2000458 | astrocyte chemotaxis(GO:0035700) regulation of astrocyte chemotaxis(GO:2000458) |
1.3 | 3.9 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
1.3 | 3.9 | GO:0072616 | interleukin-18 secretion(GO:0072616) |
1.1 | 4.6 | GO:0002774 | Fc receptor mediated inhibitory signaling pathway(GO:0002774) |
1.1 | 3.4 | GO:1990654 | sebum secreting cell proliferation(GO:1990654) |
1.1 | 2.2 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
1.0 | 3.1 | GO:0002818 | intracellular defense response(GO:0002818) |
1.0 | 2.1 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
1.0 | 3.9 | GO:0019417 | sulfur oxidation(GO:0019417) |
1.0 | 3.9 | GO:0002432 | granuloma formation(GO:0002432) |
1.0 | 3.9 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.9 | 2.8 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.9 | 2.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.9 | 2.7 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.9 | 0.9 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.9 | 2.6 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.9 | 2.6 | GO:0061485 | memory T cell proliferation(GO:0061485) |
0.8 | 0.8 | GO:0072678 | T cell migration(GO:0072678) |
0.8 | 3.4 | GO:0002305 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.8 | 4.2 | GO:0002925 | positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) |
0.8 | 0.8 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.8 | 9.1 | GO:0070269 | pyroptosis(GO:0070269) |
0.8 | 1.6 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
0.8 | 2.5 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
0.8 | 11.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.8 | 2.4 | GO:0034130 | toll-like receptor 1 signaling pathway(GO:0034130) |
0.8 | 1.6 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.8 | 3.9 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.8 | 2.3 | GO:2000471 | regulation of hematopoietic stem cell migration(GO:2000471) positive regulation of hematopoietic stem cell migration(GO:2000473) |
0.8 | 4.6 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.8 | 6.9 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.8 | 2.3 | GO:0044727 | DNA demethylation of male pronucleus(GO:0044727) |
0.8 | 2.3 | GO:0033037 | polysaccharide localization(GO:0033037) |
0.7 | 3.0 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.7 | 2.2 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.7 | 2.2 | GO:0040010 | positive regulation of growth rate(GO:0040010) regulation of gastric mucosal blood circulation(GO:1904344) positive regulation of gastric mucosal blood circulation(GO:1904346) gastric mucosal blood circulation(GO:1990768) |
0.7 | 2.2 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.7 | 0.7 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.7 | 5.7 | GO:0048769 | sarcomerogenesis(GO:0048769) |
0.7 | 6.3 | GO:1900625 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.7 | 5.6 | GO:0071918 | urea transmembrane transport(GO:0071918) |
0.7 | 6.3 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.7 | 12.5 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.7 | 2.8 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.7 | 9.5 | GO:0002517 | T cell tolerance induction(GO:0002517) |
0.7 | 2.7 | GO:0035397 | helper T cell enhancement of adaptive immune response(GO:0035397) |
0.7 | 4.7 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.7 | 4.6 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.7 | 6.6 | GO:0038129 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) ERBB3 signaling pathway(GO:0038129) |
0.7 | 5.3 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.7 | 2.0 | GO:0002881 | negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.6 | 3.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.6 | 1.9 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.6 | 1.9 | GO:0045554 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.6 | 5.7 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.6 | 1.9 | GO:1902823 | negative regulation of late endosome to lysosome transport(GO:1902823) |
0.6 | 4.3 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
0.6 | 3.6 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) positive regulation of natural killer cell cytokine production(GO:0002729) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
0.6 | 3.6 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.6 | 2.3 | GO:0032764 | negative regulation of mast cell cytokine production(GO:0032764) |
0.6 | 2.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.6 | 2.3 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.6 | 7.9 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.6 | 2.2 | GO:0034721 | histone H3-K4 demethylation, trimethyl-H3-K4-specific(GO:0034721) |
0.6 | 6.1 | GO:2000334 | blood microparticle formation(GO:0072564) regulation of blood microparticle formation(GO:2000332) positive regulation of blood microparticle formation(GO:2000334) |
0.6 | 0.6 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
0.6 | 0.6 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.5 | 1.6 | GO:0032824 | negative regulation of natural killer cell differentiation(GO:0032824) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.5 | 2.2 | GO:0046061 | dATP catabolic process(GO:0046061) |
0.5 | 2.2 | GO:0002857 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.5 | 2.7 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.5 | 1.1 | GO:1903526 | negative regulation of membrane tubulation(GO:1903526) |
0.5 | 2.1 | GO:1903770 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
0.5 | 0.5 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.5 | 1.6 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.5 | 70.9 | GO:0031295 | T cell costimulation(GO:0031295) |
0.5 | 6.2 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.5 | 7.6 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.5 | 2.5 | GO:0071409 | cellular response to cycloheximide(GO:0071409) |
0.5 | 1.0 | GO:0032618 | interleukin-15 production(GO:0032618) |
0.5 | 5.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.5 | 2.4 | GO:1904882 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.5 | 2.4 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.5 | 2.9 | GO:1900147 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.5 | 2.4 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.5 | 2.9 | GO:2000537 | regulation of B cell chemotaxis(GO:2000537) positive regulation of B cell chemotaxis(GO:2000538) |
0.5 | 1.4 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) regulation of natural killer cell differentiation involved in immune response(GO:0032826) regulation of extrathymic T cell differentiation(GO:0033082) |
0.5 | 0.9 | GO:1902567 | negative regulation of eosinophil activation(GO:1902567) |
0.5 | 2.8 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.5 | 2.8 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
0.5 | 3.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.5 | 5.6 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.5 | 2.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.5 | 8.8 | GO:0002717 | positive regulation of natural killer cell mediated immunity(GO:0002717) |
0.5 | 1.8 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.5 | 1.8 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.5 | 0.5 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.5 | 2.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.5 | 9.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.5 | 3.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 1.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.4 | 1.8 | GO:0019442 | tryptophan catabolic process to acetyl-CoA(GO:0019442) |
0.4 | 1.3 | GO:1902565 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.4 | 4.0 | GO:0051873 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
0.4 | 0.4 | GO:1903433 | regulation of constitutive secretory pathway(GO:1903433) |
0.4 | 1.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
0.4 | 3.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
0.4 | 1.3 | GO:0032203 | telomere formation via telomerase(GO:0032203) |
0.4 | 2.1 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.4 | 0.4 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.4 | 1.3 | GO:1902948 | regulation of choline O-acetyltransferase activity(GO:1902769) positive regulation of choline O-acetyltransferase activity(GO:1902771) negative regulation of tau-protein kinase activity(GO:1902948) positive regulation of early endosome to recycling endosome transport(GO:1902955) negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902960) negative regulation of neurofibrillary tangle assembly(GO:1902997) negative regulation of aspartic-type peptidase activity(GO:1905246) |
0.4 | 1.3 | GO:0061056 | sclerotome development(GO:0061056) |
0.4 | 1.7 | GO:0001878 | response to yeast(GO:0001878) |
0.4 | 0.4 | GO:1904000 | positive regulation of eating behavior(GO:1904000) |
0.4 | 8.0 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.4 | 2.1 | GO:0010636 | positive regulation of mitochondrial fusion(GO:0010636) |
0.4 | 4.2 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.4 | 0.4 | GO:0043307 | eosinophil activation(GO:0043307) |
0.4 | 3.3 | GO:0006083 | acetate metabolic process(GO:0006083) |
0.4 | 1.2 | GO:0060927 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) |
0.4 | 1.6 | GO:1902963 | regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
0.4 | 2.4 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.4 | 2.4 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.4 | 2.8 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.4 | 1.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.4 | 8.7 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 2.0 | GO:2000568 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.4 | 0.8 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.4 | 0.8 | GO:0014040 | positive regulation of Schwann cell differentiation(GO:0014040) |
0.4 | 1.6 | GO:1904978 | regulation of endosome organization(GO:1904978) |
0.4 | 2.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.4 | 2.3 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.4 | 0.8 | GO:0006788 | heme oxidation(GO:0006788) |
0.4 | 1.1 | GO:0098939 | dendritic transport of mitochondrion(GO:0098939) anterograde dendritic transport of mitochondrion(GO:0098972) |
0.4 | 1.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 0.8 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
0.4 | 0.4 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
0.4 | 2.3 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.4 | 3.0 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
0.4 | 1.5 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.4 | 0.4 | GO:0002645 | positive regulation of tolerance induction(GO:0002645) |
0.4 | 2.2 | GO:0036493 | positive regulation of translation in response to endoplasmic reticulum stress(GO:0036493) |
0.4 | 1.1 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.4 | 1.8 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.4 | 2.2 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.4 | 1.1 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.4 | 1.8 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
0.4 | 1.8 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.4 | 1.4 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.4 | 1.4 | GO:0015785 | UDP-galactose transport(GO:0015785) UDP-galactose transmembrane transport(GO:0072334) |
0.4 | 0.4 | GO:0031627 | telomeric loop formation(GO:0031627) |
0.4 | 3.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.4 | 3.9 | GO:0018377 | protein myristoylation(GO:0018377) |
0.4 | 1.4 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.4 | 1.1 | GO:1901076 | positive regulation of engulfment of apoptotic cell(GO:1901076) |
0.4 | 6.7 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.4 | 1.4 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.4 | 3.9 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.3 | 1.0 | GO:0071901 | negative regulation of protein serine/threonine kinase activity(GO:0071901) |
0.3 | 2.4 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.3 | 1.7 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
0.3 | 3.4 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.3 | 0.3 | GO:0060460 | left lung development(GO:0060459) left lung morphogenesis(GO:0060460) |
0.3 | 1.0 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.3 | 0.3 | GO:0051788 | response to misfolded protein(GO:0051788) |
0.3 | 1.7 | GO:0007525 | somatic muscle development(GO:0007525) |
0.3 | 1.7 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of interleukin-12 secretion(GO:2001184) |
0.3 | 1.7 | GO:0015788 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.3 | 2.6 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 4.0 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.3 | 0.7 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 3.6 | GO:0032264 | IMP salvage(GO:0032264) |
0.3 | 0.3 | GO:0061009 | common bile duct development(GO:0061009) |
0.3 | 2.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.3 | 4.6 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.3 | 0.7 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.3 | 1.0 | GO:0048597 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.3 | 1.3 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.3 | 3.2 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.3 | 0.6 | GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) |
0.3 | 1.6 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.3 | 2.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.3 | 0.9 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.3 | 1.3 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.3 | 1.3 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.3 | 1.6 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.3 | 0.9 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.3 | 3.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.3 | 2.5 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.3 | 4.6 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.3 | 0.9 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.3 | 3.3 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.3 | 0.3 | GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process(GO:0051771) |
0.3 | 0.9 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.3 | 1.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.3 | 0.9 | GO:2000616 | negative regulation of histone H3-K9 acetylation(GO:2000616) |
0.3 | 0.9 | GO:0043091 | L-arginine import(GO:0043091) arginine import(GO:0090467) |
0.3 | 2.4 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.3 | 0.9 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 1.2 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.3 | 0.9 | GO:0003245 | cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
0.3 | 0.9 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
0.3 | 1.2 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
0.3 | 5.2 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.3 | 2.9 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.3 | 0.9 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.3 | 1.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 1.2 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.3 | 0.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.3 | 0.9 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.3 | 0.6 | GO:0046102 | inosine metabolic process(GO:0046102) |
0.3 | 2.6 | GO:1902748 | positive regulation of lens fiber cell differentiation(GO:1902748) |
0.3 | 0.9 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.3 | 1.7 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.3 | 2.5 | GO:0008582 | regulation of synaptic growth at neuromuscular junction(GO:0008582) |
0.3 | 4.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.3 | 3.4 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.3 | 0.8 | GO:0032516 | positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
0.3 | 2.2 | GO:1902856 | negative regulation of nonmotile primary cilium assembly(GO:1902856) |
0.3 | 1.4 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.3 | 0.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.3 | 0.8 | GO:0080121 | coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
0.3 | 1.4 | GO:1904685 | positive regulation of metalloendopeptidase activity(GO:1904685) |
0.3 | 0.6 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.3 | 1.9 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.3 | 4.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.3 | 2.2 | GO:0006623 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) |
0.3 | 0.8 | GO:0031587 | positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0031587) |
0.3 | 0.5 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
0.3 | 0.8 | GO:2000407 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:0035698) positive regulation of necroptotic process(GO:0060545) regulation of T cell extravasation(GO:2000407) regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000449) regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation(GO:2000452) |
0.3 | 0.5 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.3 | 0.8 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.3 | 0.5 | GO:0015840 | urea transport(GO:0015840) |
0.3 | 0.3 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 0.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.3 | 3.5 | GO:0044351 | macropinocytosis(GO:0044351) |
0.3 | 0.8 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) suppression by virus of host autophagy(GO:0039521) |
0.3 | 1.3 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
0.3 | 1.0 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.3 | 5.0 | GO:0043306 | positive regulation of mast cell activation(GO:0033005) positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.3 | 2.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 1.3 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
0.3 | 0.8 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.3 | 2.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.3 | 1.6 | GO:1902045 | negative regulation of Fas signaling pathway(GO:1902045) |
0.3 | 2.1 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.3 | 1.0 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.3 | 0.8 | GO:0045083 | negative regulation of interleukin-12 biosynthetic process(GO:0045083) |
0.3 | 0.8 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.3 | 1.0 | GO:0003363 | lamellipodium assembly involved in ameboidal cell migration(GO:0003363) extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration(GO:0021816) |
0.3 | 1.5 | GO:0043271 | negative regulation of ion transport(GO:0043271) |
0.3 | 0.3 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.3 | 3.8 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.3 | 1.0 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
0.3 | 0.8 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 0.3 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.3 | 0.8 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.3 | 0.8 | GO:1990637 | response to prolactin(GO:1990637) |
0.3 | 1.0 | GO:0002625 | regulation of T cell antigen processing and presentation(GO:0002625) |
0.3 | 0.8 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
0.2 | 3.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 1.7 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.2 | 0.7 | GO:0036060 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.2 | 0.7 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.2 | 1.2 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.2 | 0.7 | GO:1904211 | membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
0.2 | 1.0 | GO:0035482 | gastric motility(GO:0035482) gastric emptying(GO:0035483) |
0.2 | 10.1 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.2 | 1.0 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.2 | 0.7 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.2 | 0.5 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.2 | 0.7 | GO:0032753 | positive regulation of interleukin-4 production(GO:0032753) |
0.2 | 17.2 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 1.7 | GO:0019075 | virus maturation(GO:0019075) |
0.2 | 0.5 | GO:0001953 | negative regulation of cell-matrix adhesion(GO:0001953) |
0.2 | 1.0 | GO:0030035 | microspike assembly(GO:0030035) |
0.2 | 0.5 | GO:0019915 | lipid storage(GO:0019915) |
0.2 | 0.7 | GO:0036333 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.2 | 0.7 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 0.5 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.2 | 1.4 | GO:0010816 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.2 | 0.9 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.2 | 0.9 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
0.2 | 0.5 | GO:2000742 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
0.2 | 3.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.2 | 1.9 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.2 | 0.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.2 | 1.6 | GO:0010572 | positive regulation of platelet activation(GO:0010572) |
0.2 | 0.5 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.2 | 0.7 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.2 | 1.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 0.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.2 | 1.6 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.2 | 3.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.2 | 1.8 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.2 | 0.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.2 | 0.9 | GO:0070895 | transposon integration(GO:0070893) regulation of transposon integration(GO:0070894) negative regulation of transposon integration(GO:0070895) |
0.2 | 0.7 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.2 | 2.0 | GO:1901341 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.2 | 1.4 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.2 | 2.3 | GO:1902563 | regulation of neutrophil activation(GO:1902563) |
0.2 | 1.1 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.2 | 0.7 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 0.4 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.2 | 40.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.2 | 0.7 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) positive regulation of microtubule binding(GO:1904528) |
0.2 | 3.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.2 | 2.2 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.2 | 2.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.2 | 1.8 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 2.9 | GO:0060059 | embryonic retina morphogenesis in camera-type eye(GO:0060059) |
0.2 | 2.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.2 | 0.9 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
0.2 | 2.0 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.2 | 0.4 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.2 | 0.7 | GO:1904897 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.2 | 4.1 | GO:0002335 | mature B cell differentiation(GO:0002335) |
0.2 | 2.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.9 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
0.2 | 1.7 | GO:1901297 | positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
0.2 | 0.4 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.2 | 0.6 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.2 | 1.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.2 | 1.7 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
0.2 | 0.6 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.2 | 2.8 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.2 | 1.1 | GO:0008204 | ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
0.2 | 1.7 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.2 | 0.9 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.2 | 10.2 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.2 | 1.3 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.2 | 1.3 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 4.7 | GO:0043485 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.2 | 0.2 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.2 | 0.4 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.2 | 0.8 | GO:0006238 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.2 | 4.6 | GO:0071397 | cellular response to cholesterol(GO:0071397) |
0.2 | 0.4 | GO:0044111 | development involved in symbiotic interaction(GO:0044111) |
0.2 | 1.5 | GO:0061767 | negative regulation of lung blood pressure(GO:0061767) |
0.2 | 1.3 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
0.2 | 0.4 | GO:0033029 | neutrophil apoptotic process(GO:0001781) regulation of neutrophil apoptotic process(GO:0033029) |
0.2 | 1.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 1.9 | GO:0006772 | thiamine metabolic process(GO:0006772) |
0.2 | 3.1 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.2 | 0.8 | GO:1902361 | mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
0.2 | 1.2 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.2 | 0.8 | GO:1901475 | pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
0.2 | 4.7 | GO:0045730 | respiratory burst(GO:0045730) |
0.2 | 1.0 | GO:0052148 | modulation by virus of host molecular function(GO:0039506) suppression by virus of host molecular function(GO:0039507) suppression by virus of host catalytic activity(GO:0039513) modulation by virus of host catalytic activity(GO:0039516) suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process(GO:0039650) negative regulation by symbiont of host catalytic activity(GO:0052053) negative regulation by symbiont of host molecular function(GO:0052056) modulation by symbiont of host catalytic activity(GO:0052148) |
0.2 | 0.4 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.2 | 4.9 | GO:0045577 | regulation of B cell differentiation(GO:0045577) |
0.2 | 4.1 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.2 | 2.0 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.6 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.2 | 0.6 | GO:0070175 | positive regulation of enamel mineralization(GO:0070175) |
0.2 | 0.8 | GO:0036228 | protein targeting to nuclear inner membrane(GO:0036228) |
0.2 | 0.8 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
0.2 | 3.2 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.6 | GO:0061582 | colon epithelial cell migration(GO:0061580) intestinal epithelial cell migration(GO:0061582) |
0.2 | 0.6 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.2 | 0.6 | GO:1904924 | negative regulation of mitophagy in response to mitochondrial depolarization(GO:1904924) |
0.2 | 2.0 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.8 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.2 | 0.2 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.2 | 0.6 | GO:0051097 | negative regulation of helicase activity(GO:0051097) oligodendrocyte apoptotic process(GO:0097252) |
0.2 | 1.6 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.2 | 2.4 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.2 | 1.4 | GO:0052204 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) modification by host of symbiont molecular function(GO:0052428) |
0.2 | 1.4 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.2 | 2.8 | GO:0010763 | positive regulation of fibroblast migration(GO:0010763) |
0.2 | 0.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.2 | 1.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 2.0 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.2 | 0.8 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.2 | 0.6 | GO:0034402 | recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex(GO:0034402) |
0.2 | 1.4 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
0.2 | 5.5 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.2 | 0.8 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.2 | 0.6 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
0.2 | 1.0 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.2 | 1.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.2 | 5.6 | GO:0030101 | natural killer cell activation(GO:0030101) |
0.2 | 2.5 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
0.2 | 2.7 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.2 | 2.5 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 2.1 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 0.8 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.2 | 1.9 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.2 | 0.6 | GO:0060304 | regulation of phosphatidylinositol dephosphorylation(GO:0060304) |
0.2 | 0.2 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.2 | 14.3 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.2 | 0.6 | GO:0019082 | viral protein processing(GO:0019082) negative regulation of low-density lipoprotein particle receptor catabolic process(GO:0032804) regulation of nerve growth factor production(GO:0032903) negative regulation of nerve growth factor production(GO:0032904) dibasic protein processing(GO:0090472) |
0.2 | 1.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.2 | 1.5 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.2 | 2.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 2.0 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.2 | 0.4 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
0.2 | 2.0 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.2 | 0.4 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.2 | 0.9 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 0.9 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.2 | 1.1 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
0.2 | 0.7 | GO:1903060 | regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
0.2 | 0.5 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.2 | 0.2 | GO:0071371 | cellular response to gonadotropin stimulus(GO:0071371) |
0.2 | 4.1 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.2 | 6.4 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
0.2 | 0.9 | GO:0001555 | oocyte growth(GO:0001555) |
0.2 | 0.7 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.2 | 2.7 | GO:0045141 | meiotic telomere clustering(GO:0045141) |
0.2 | 1.1 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.2 | 0.7 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
0.2 | 1.4 | GO:0006235 | dTTP biosynthetic process(GO:0006235) pyrimidine deoxyribonucleoside triphosphate biosynthetic process(GO:0009212) |
0.2 | 7.2 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.5 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.2 | 0.7 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.2 | 0.7 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.2 | 2.1 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 23.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.2 | 0.3 | GO:0035669 | TRAM-dependent toll-like receptor signaling pathway(GO:0035668) TRAM-dependent toll-like receptor 4 signaling pathway(GO:0035669) |
0.2 | 0.3 | GO:0031000 | response to caffeine(GO:0031000) cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.2 | 0.7 | GO:1904647 | response to rotenone(GO:1904647) |
0.2 | 1.4 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.9 | GO:1904450 | gamma-aminobutyric acid catabolic process(GO:0009450) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) positive regulation of prolactin secretion(GO:1902722) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.2 | 1.4 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 2.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.3 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.2 | 2.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.9 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.2 | 0.7 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.2 | 1.9 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.3 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.2 | 7.9 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 1.0 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 1.0 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.2 | 1.8 | GO:1901299 | negative regulation of hydrogen peroxide-mediated programmed cell death(GO:1901299) |
0.2 | 2.3 | GO:0050856 | regulation of T cell receptor signaling pathway(GO:0050856) |
0.2 | 1.5 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 1.2 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 2.3 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.2 | 0.7 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.2 | 0.5 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.2 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.2 | 0.5 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.2 | 4.6 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.2 | 4.6 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 1.1 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.2 | 1.3 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.2 | 1.1 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 1.0 | GO:1903147 | negative regulation of macromitophagy(GO:1901525) negative regulation of mitophagy(GO:1903147) |
0.2 | 0.6 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.2 | 3.9 | GO:0016180 | snRNA processing(GO:0016180) |
0.2 | 0.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.2 | 6.5 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.2 | 0.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.2 | 107.8 | GO:0042119 | neutrophil activation(GO:0042119) |
0.2 | 1.6 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.2 | 6.6 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.2 | 0.8 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
0.2 | 0.2 | GO:1901623 | regulation of lymphocyte chemotaxis(GO:1901623) |
0.2 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.5 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 1.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.2 | 0.5 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
0.2 | 2.8 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.8 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.2 | 0.5 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 0.9 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
0.2 | 1.2 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.2 | 0.5 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.2 | 4.5 | GO:0001556 | oocyte maturation(GO:0001556) |
0.2 | 0.9 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.6 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.2 | 0.8 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 6.2 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.2 | 0.2 | GO:0014839 | myoblast migration involved in skeletal muscle regeneration(GO:0014839) |
0.2 | 0.5 | GO:1904116 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
0.2 | 1.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.2 | 1.4 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 1.6 | GO:0043368 | positive T cell selection(GO:0043368) |
0.1 | 0.6 | GO:0050758 | thymidylate synthase biosynthetic process(GO:0050757) regulation of thymidylate synthase biosynthetic process(GO:0050758) |
0.1 | 1.3 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
0.1 | 1.2 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
0.1 | 0.3 | GO:0002863 | positive regulation of inflammatory response to antigenic stimulus(GO:0002863) |
0.1 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.4 | GO:0044782 | cilium organization(GO:0044782) |
0.1 | 0.4 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.6 | GO:0034445 | negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.1 | 0.7 | GO:0007172 | signal complex assembly(GO:0007172) |
0.1 | 1.9 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.9 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.6 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 0.6 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
0.1 | 2.6 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 4.1 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 1.3 | GO:0007000 | nucleolus organization(GO:0007000) |
0.1 | 1.0 | GO:0002407 | dendritic cell chemotaxis(GO:0002407) |
0.1 | 0.8 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.3 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
0.1 | 0.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.1 | 1.4 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.1 | 0.4 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.1 | 0.4 | GO:0021503 | neural fold bending(GO:0021503) |
0.1 | 0.8 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.1 | 0.3 | GO:0090398 | cellular senescence(GO:0090398) |
0.1 | 0.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.1 | 0.7 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
0.1 | 10.2 | GO:0030397 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.1 | 0.3 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.1 | 1.6 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.8 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.1 | 0.5 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.1 | 1.8 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.1 | 2.0 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.3 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.1 | 1.5 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 8.4 | GO:0007040 | lysosome organization(GO:0007040) lytic vacuole organization(GO:0080171) |
0.1 | 2.1 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
0.1 | 0.5 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.1 | 4.0 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 2.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.4 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 1.8 | GO:0010661 | positive regulation of muscle cell apoptotic process(GO:0010661) |
0.1 | 1.7 | GO:0007035 | vacuolar acidification(GO:0007035) |
0.1 | 1.3 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.1 | 0.7 | GO:0007402 | ganglion mother cell fate determination(GO:0007402) |
0.1 | 0.7 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 1.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.9 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.1 | 1.0 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.5 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.6 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.1 | 2.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.5 | GO:2000176 | regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.1 | 2.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 1.0 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 2.3 | GO:0019081 | viral translation(GO:0019081) |
0.1 | 0.3 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.9 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 6.6 | GO:0006968 | cellular defense response(GO:0006968) |
0.1 | 0.4 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.1 | 0.9 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 2.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.1 | 0.3 | GO:2000836 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
0.1 | 0.6 | GO:0048241 | epinephrine transport(GO:0048241) |
0.1 | 0.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 0.1 | GO:0046469 | platelet activating factor biosynthetic process(GO:0006663) platelet activating factor metabolic process(GO:0046469) |
0.1 | 5.6 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.1 | GO:0032414 | positive regulation of ion transmembrane transporter activity(GO:0032414) |
0.1 | 0.9 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.1 | 0.7 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 2.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.9 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 0.9 | GO:1902164 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
0.1 | 0.9 | GO:0072539 | cellular response to sterol(GO:0036315) T-helper 17 cell differentiation(GO:0072539) |
0.1 | 0.2 | GO:0000965 | mitochondrial RNA 3'-end processing(GO:0000965) |
0.1 | 0.4 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 0.8 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.1 | 0.1 | GO:1904106 | protein localization to microvillus(GO:1904106) |
0.1 | 0.4 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.1 | 0.4 | GO:0048505 | regulation of development, heterochronic(GO:0040034) regulation of timing of cell differentiation(GO:0048505) |
0.1 | 0.4 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
0.1 | 0.5 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
0.1 | 0.6 | GO:0071440 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.7 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.1 | 1.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.1 | 1.4 | GO:0042110 | T cell activation(GO:0042110) T cell aggregation(GO:0070489) lymphocyte aggregation(GO:0071593) |
0.1 | 0.6 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.1 | 1.1 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.5 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.1 | 1.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.1 | 0.7 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.6 | GO:0015822 | mitochondrial ornithine transport(GO:0000066) ornithine transport(GO:0015822) |
0.1 | 0.2 | GO:0070874 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.7 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.1 | 1.2 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 4.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 2.1 | GO:0045199 | maintenance of apical/basal cell polarity(GO:0035090) maintenance of epithelial cell apical/basal polarity(GO:0045199) |
0.1 | 0.3 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.1 | 0.2 | GO:1904875 | regulation of DNA ligase activity(GO:1904875) |
0.1 | 0.1 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.1 | 1.5 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.1 | 3.4 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 1.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.2 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.1 | 0.4 | GO:0050992 | dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
0.1 | 0.7 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.1 | 0.8 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.1 | 0.7 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.1 | 0.8 | GO:0032736 | positive regulation of interleukin-13 production(GO:0032736) |
0.1 | 0.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.4 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.4 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.1 | 8.0 | GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent(GO:0002479) |
0.1 | 0.4 | GO:1902603 | carnitine transmembrane transport(GO:1902603) |
0.1 | 0.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.1 | 1.7 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.1 | 1.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.1 | 0.8 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 0.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.1 | 0.4 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.1 | 0.2 | GO:0019085 | early viral transcription(GO:0019085) |
0.1 | 2.6 | GO:0051569 | regulation of histone H3-K4 methylation(GO:0051569) |
0.1 | 0.4 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 1.1 | GO:0032418 | lysosome localization(GO:0032418) |
0.1 | 0.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 1.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 1.2 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 7.4 | GO:0045652 | regulation of megakaryocyte differentiation(GO:0045652) |
0.1 | 0.5 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.1 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 0.3 | GO:0002327 | immature B cell differentiation(GO:0002327) |
0.1 | 0.3 | GO:0034093 | positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
0.1 | 0.2 | GO:0043634 | polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) |
0.1 | 1.9 | GO:0090312 | positive regulation of protein deacetylation(GO:0090312) |
0.1 | 0.5 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.1 | 1.9 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.1 | 0.3 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.1 | 0.7 | GO:0051176 | positive regulation of sulfur metabolic process(GO:0051176) |
0.1 | 0.5 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.3 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.1 | 0.2 | GO:0051180 | vitamin transport(GO:0051180) |
0.1 | 0.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.2 | GO:0015965 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 0.5 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.5 | GO:1904798 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.1 | 0.3 | GO:0000726 | non-recombinational repair(GO:0000726) |
0.1 | 1.7 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.5 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 5.8 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 3.5 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 0.8 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.2 | GO:0006700 | C21-steroid hormone biosynthetic process(GO:0006700) |
0.1 | 0.3 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.1 | 0.5 | GO:0061081 | positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.1 | 0.7 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.1 | 0.4 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.1 | 2.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 3.4 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 1.2 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.6 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal lipid absorption(GO:1904729) |
0.1 | 1.8 | GO:0016246 | RNA interference(GO:0016246) |
0.1 | 0.4 | GO:0071896 | protein localization to adherens junction(GO:0071896) |
0.1 | 0.4 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.5 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 1.2 | GO:0036344 | platelet formation(GO:0030220) platelet morphogenesis(GO:0036344) |
0.1 | 1.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.3 | GO:0002265 | astrocyte activation involved in immune response(GO:0002265) |
0.1 | 1.4 | GO:0014877 | response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.3 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.8 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 0.2 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
0.1 | 0.5 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.3 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.1 | 0.2 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.1 | 1.3 | GO:0090263 | positive regulation of canonical Wnt signaling pathway(GO:0090263) |
0.1 | 0.9 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.1 | 0.7 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.1 | 0.9 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
0.1 | 0.8 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 1.0 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.5 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 3.4 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 1.2 | GO:0030219 | megakaryocyte differentiation(GO:0030219) |
0.1 | 0.9 | GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000059) |
0.1 | 0.6 | GO:0072584 | caveolin-mediated endocytosis(GO:0072584) |
0.1 | 0.8 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
0.1 | 1.7 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 1.7 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.6 | GO:0051697 | protein delipidation(GO:0051697) |
0.1 | 0.4 | GO:0071105 | response to interleukin-11(GO:0071105) cellular response to interleukin-11(GO:0071348) |
0.1 | 0.2 | GO:1901096 | regulation of autophagosome maturation(GO:1901096) |
0.1 | 2.9 | GO:0030183 | B cell differentiation(GO:0030183) |
0.1 | 1.7 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.2 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.1 | 0.4 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 0.4 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.1 | 0.5 | GO:0010650 | positive regulation of cell communication by electrical coupling(GO:0010650) |
0.1 | 0.4 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 2.0 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.1 | 0.6 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.1 | 0.5 | GO:0042269 | regulation of natural killer cell mediated immunity(GO:0002715) regulation of natural killer cell mediated cytotoxicity(GO:0042269) |
0.1 | 0.4 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 0.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
0.1 | 0.3 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.1 | 1.1 | GO:1904816 | regulation of protein localization to chromosome, telomeric region(GO:1904814) positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 0.3 | GO:0045333 | cellular respiration(GO:0045333) |
0.1 | 0.4 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.5 | GO:0019418 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.1 | 1.0 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.5 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.1 | 0.3 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.1 | 2.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 1.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.1 | 1.2 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.1 | 0.6 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.1 | 2.2 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.3 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.1 | 0.3 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.3 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 2.4 | GO:0046834 | lipid phosphorylation(GO:0046834) phosphatidylinositol phosphorylation(GO:0046854) |
0.1 | 0.3 | GO:0033319 | UDP-D-xylose metabolic process(GO:0033319) UDP-D-xylose biosynthetic process(GO:0033320) |
0.1 | 0.3 | GO:0014046 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 1.9 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.6 | GO:0098542 | defense response to other organism(GO:0098542) |
0.1 | 1.7 | GO:0000394 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) |
0.1 | 0.3 | GO:1900125 | regulation of hyaluronan biosynthetic process(GO:1900125) |
0.1 | 0.3 | GO:2001178 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.1 | 1.6 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.6 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.1 | 0.4 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.1 | 0.6 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 1.1 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 0.1 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.1 | 0.6 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.8 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 1.4 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.1 | 0.2 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
0.1 | 5.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.6 | GO:1902952 | positive regulation of dendritic spine maintenance(GO:1902952) regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903756) negative regulation of transcription from RNA polymerase II promoter by histone modification(GO:1903758) |
0.1 | 0.2 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.1 | 0.2 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 0.2 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.1 | 2.5 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.2 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.6 | GO:0031998 | regulation of fatty acid beta-oxidation(GO:0031998) |
0.1 | 0.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.1 | 0.8 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.1 | 0.7 | GO:0010165 | response to X-ray(GO:0010165) |
0.1 | 3.8 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.1 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.7 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.2 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.5 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.7 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.1 | 0.6 | GO:0060746 | maternal behavior(GO:0042711) parental behavior(GO:0060746) |
0.1 | 0.3 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.2 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 0.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 1.6 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.8 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
0.1 | 2.5 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.1 | 1.0 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.1 | 0.3 | GO:0044245 | polysaccharide digestion(GO:0044245) |
0.1 | 1.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.1 | GO:0048387 | regulation of retinoic acid receptor signaling pathway(GO:0048385) negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 0.2 | GO:0031204 | posttranslational protein targeting to membrane, translocation(GO:0031204) |
0.1 | 0.4 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.1 | 0.6 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.1 | 0.7 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.1 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.1 | 0.7 | GO:0090148 | membrane fission(GO:0090148) |
0.1 | 0.7 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.2 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.1 | 0.8 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.1 | 0.6 | GO:0060453 | regulation of gastric acid secretion(GO:0060453) |
0.1 | 1.7 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.2 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.4 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.1 | 0.4 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 2.2 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.5 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) |
0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.4 | GO:0030242 | pexophagy(GO:0030242) |
0.1 | 0.3 | GO:1990167 | protein K27-linked deubiquitination(GO:1990167) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.6 | GO:1903432 | regulation of TORC1 signaling(GO:1903432) |
0.1 | 1.9 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.1 | 0.2 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.1 | 0.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
0.1 | 0.4 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.7 | GO:1901315 | negative regulation of histone ubiquitination(GO:0033183) histone H2A K63-linked ubiquitination(GO:0070535) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.1 | GO:0009452 | 7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.1 | 0.3 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.1 | 0.7 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
0.1 | 0.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.6 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.1 | 0.7 | GO:0014029 | neural crest formation(GO:0014029) |
0.1 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 0.9 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 0.3 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.1 | 0.6 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.1 | 0.2 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.1 | 0.6 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.3 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.1 | 0.7 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.4 | GO:0009994 | oocyte differentiation(GO:0009994) |
0.1 | 0.4 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.1 | 0.5 | GO:0015985 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.1 | 0.4 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.1 | 0.1 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.1 | 0.8 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.1 | 0.3 | GO:0071887 | leukocyte apoptotic process(GO:0071887) |
0.1 | 7.4 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 1.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.4 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.1 | 0.2 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) |
0.1 | 0.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 3.3 | GO:0070671 | response to interleukin-12(GO:0070671) |
0.1 | 0.4 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
0.1 | 0.2 | GO:0051198 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.1 | 0.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.7 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:1902018 | negative regulation of cilium assembly(GO:1902018) |
0.1 | 0.8 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.2 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.1 | 0.2 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.1 | 0.2 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.2 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.1 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.1 | 1.6 | GO:0010458 | exit from mitosis(GO:0010458) |
0.1 | 0.4 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.5 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
0.1 | 0.8 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.1 | 2.1 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.1 | 1.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.1 | 0.2 | GO:0006116 | NADH oxidation(GO:0006116) |
0.1 | 0.6 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.1 | 1.8 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.1 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 1.3 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.1 | 0.5 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.1 | 0.1 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.1 | 0.6 | GO:0046049 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.1 | 0.5 | GO:0098760 | interleukin-7-mediated signaling pathway(GO:0038111) response to interleukin-7(GO:0098760) cellular response to interleukin-7(GO:0098761) |
0.1 | 0.2 | GO:0035627 | ER to Golgi ceramide transport(GO:0035621) ceramide transport(GO:0035627) |
0.1 | 0.2 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.3 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.1 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 3.5 | GO:0032481 | positive regulation of type I interferon production(GO:0032481) |
0.1 | 1.8 | GO:0051646 | mitochondrion localization(GO:0051646) |
0.1 | 0.1 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.1 | 0.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.1 | 0.3 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.8 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 0.8 | GO:0072662 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.2 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.1 | 0.1 | GO:0071389 | cellular response to mineralocorticoid stimulus(GO:0071389) |
0.1 | 0.1 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.1 | 0.1 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 0.7 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 1.2 | GO:1901663 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 1.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.1 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.8 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 0.2 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 1.0 | GO:0035666 | TRIF-dependent toll-like receptor signaling pathway(GO:0035666) |
0.1 | 1.0 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.7 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.1 | 0.2 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.3 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.1 | 0.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
0.1 | 0.1 | GO:2000035 | regulation of stem cell division(GO:2000035) |
0.1 | 0.3 | GO:0000732 | strand displacement(GO:0000732) |
0.1 | 0.9 | GO:2001204 | regulation of osteoclast development(GO:2001204) |
0.1 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.1 | 0.3 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.1 | 0.7 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 2.1 | GO:1902750 | negative regulation of cell cycle G2/M phase transition(GO:1902750) |
0.1 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.1 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.1 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.5 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
0.1 | 0.5 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 4.0 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.2 | GO:0071688 | myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 1.7 | GO:0051439 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051436) regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
0.0 | 0.7 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 2.0 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.0 | 0.1 | GO:0021554 | optic nerve development(GO:0021554) |
0.0 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 1.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.0 | 1.0 | GO:0090280 | positive regulation of calcium ion import(GO:0090280) |
0.0 | 0.8 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.0 | 0.1 | GO:0043648 | dicarboxylic acid metabolic process(GO:0043648) |
0.0 | 1.1 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.0 | 1.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.5 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 0.3 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.1 | GO:0030917 | rostrocaudal neural tube patterning(GO:0021903) midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.1 | GO:1903405 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) protein localization to nucleoplasm(GO:1990173) |
0.0 | 0.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.2 | GO:0072086 | specification of loop of Henle identity(GO:0072086) |
0.0 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.5 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.0 | 1.0 | GO:0016577 | histone demethylation(GO:0016577) |
0.0 | 0.5 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 1.0 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.2 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) negative regulation of protein folding(GO:1903333) |
0.0 | 0.3 | GO:2000143 | negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.0 | 10.0 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.6 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.6 | GO:0060008 | Sertoli cell differentiation(GO:0060008) |
0.0 | 0.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.0 | 0.2 | GO:1901569 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.0 | 0.1 | GO:0021764 | amygdala development(GO:0021764) |
0.0 | 0.2 | GO:0015853 | adenine transport(GO:0015853) |
0.0 | 0.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.0 | 2.1 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 1.7 | GO:0009303 | rRNA transcription(GO:0009303) |
0.0 | 0.2 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.0 | 0.1 | GO:0033488 | cholesterol biosynthetic process via 24,25-dihydrolanosterol(GO:0033488) |
0.0 | 0.2 | GO:0032202 | telomere assembly(GO:0032202) |
0.0 | 0.3 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 1.0 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.1 | GO:0002182 | cytoplasmic translational elongation(GO:0002182) regulation of cytoplasmic translational elongation(GO:1900247) negative regulation of cytoplasmic translational elongation(GO:1900248) |
0.0 | 0.3 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.0 | 1.6 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.0 | 0.5 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.0 | 0.1 | GO:0060292 | long term synaptic depression(GO:0060292) |
0.0 | 0.4 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.0 | 0.2 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.7 | GO:0044247 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
0.0 | 0.2 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.0 | 0.3 | GO:0060356 | leucine import(GO:0060356) |
0.0 | 0.4 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.0 | 0.1 | GO:0016093 | polyprenol metabolic process(GO:0016093) polyprenol biosynthetic process(GO:0016094) |
0.0 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.2 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.0 | 0.4 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.0 | 0.7 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.0 | 0.4 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.0 | 0.9 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 1.1 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 0.3 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.0 | 0.8 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.3 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
0.0 | 0.5 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.0 | 0.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.0 | 0.4 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.0 | 0.8 | GO:0006487 | protein N-linked glycosylation(GO:0006487) |
0.0 | 0.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.1 | GO:1904646 | cellular response to beta-amyloid(GO:1904646) |
0.0 | 0.9 | GO:0030262 | apoptotic nuclear changes(GO:0030262) |
0.0 | 0.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.8 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.3 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.0 | 0.7 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.0 | 0.4 | GO:0016197 | endosomal transport(GO:0016197) |
0.0 | 0.2 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.3 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.0 | 0.2 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.0 | 0.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) |
0.0 | 0.0 | GO:0002740 | negative regulation of cytokine secretion involved in immune response(GO:0002740) |
0.0 | 0.1 | GO:1902173 | negative regulation of keratinocyte apoptotic process(GO:1902173) |
0.0 | 0.5 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) galactolipid metabolic process(GO:0019374) |
0.0 | 0.3 | GO:0050715 | positive regulation of cytokine secretion(GO:0050715) |
0.0 | 0.1 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.0 | 0.5 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
0.0 | 0.9 | GO:0032204 | regulation of telomere maintenance(GO:0032204) |
0.0 | 0.3 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.0 | 0.2 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 1.2 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.4 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 1.1 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.3 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 2.0 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.0 | 0.4 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.0 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
0.0 | 0.6 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.1 | GO:1902105 | regulation of leukocyte differentiation(GO:1902105) |
0.0 | 0.2 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) |
0.0 | 0.9 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.4 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.3 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.5 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 1.1 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 0.1 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 0.2 | GO:0070777 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.0 | 0.4 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.3 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.0 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.0 | 3.2 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
0.0 | 0.3 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.0 | 4.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
0.0 | 0.7 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.1 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.0 | 0.0 | GO:0015755 | fructose transport(GO:0015755) |
0.0 | 0.1 | GO:0006941 | striated muscle contraction(GO:0006941) |
0.0 | 0.3 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.6 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.0 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.1 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.0 | 0.2 | GO:0046324 | glucose import(GO:0046323) regulation of glucose import(GO:0046324) |
0.0 | 0.1 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.0 | 0.1 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.0 | 0.3 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.0 | 0.1 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.0 | 0.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 1.9 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
0.0 | 0.1 | GO:0032225 | regulation of synaptic transmission, dopaminergic(GO:0032225) |
0.0 | 0.1 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.0 | 0.3 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
0.0 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) |
0.0 | 0.1 | GO:1902267 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.5 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.0 | 0.0 | GO:0015846 | polyamine transport(GO:0015846) |
0.0 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.0 | 0.2 | GO:0045047 | protein targeting to ER(GO:0045047) |
0.0 | 0.1 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.0 | 0.3 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.1 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.0 | 0.1 | GO:0033386 | geranylgeranyl diphosphate metabolic process(GO:0033385) geranylgeranyl diphosphate biosynthetic process(GO:0033386) |
0.0 | 0.3 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
0.0 | 0.1 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.2 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
0.0 | 0.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.0 | 0.1 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
0.0 | 0.2 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.1 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.0 | 0.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) |
0.0 | 0.2 | GO:2000169 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) regulation of peptidyl-cysteine S-nitrosylation(GO:2000169) |
0.0 | 0.2 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
0.0 | 0.3 | GO:1990001 | inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 1.4 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.0 | 0.4 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.1 | GO:0044803 | multi-organism membrane organization(GO:0044803) |
0.0 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.1 | GO:0072600 | establishment of protein localization to Golgi(GO:0072600) |
0.0 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 2.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.0 | 0.0 | GO:0006290 | pyrimidine dimer repair(GO:0006290) |
0.0 | 0.0 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.0 | 0.1 | GO:0010669 | epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.1 | GO:0048839 | inner ear development(GO:0048839) |
0.0 | 0.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 6.1 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.7 | GO:0097186 | amelogenesis(GO:0097186) |
0.0 | 1.4 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.0 | 0.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.1 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.0 | 0.8 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.1 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.4 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.2 | GO:0045069 | regulation of viral genome replication(GO:0045069) |
0.0 | 0.0 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.0 | 0.3 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 2.5 | GO:0043123 | positive regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043123) |
0.0 | 0.3 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.0 | 0.0 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
0.0 | 0.2 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.0 | 0.1 | GO:0043691 | reverse cholesterol transport(GO:0043691) |
0.0 | 0.2 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.1 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.0 | 2.4 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.0 | 0.3 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.0 | 0.6 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 1.7 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 1.6 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.0 | 0.3 | GO:0015824 | proline transport(GO:0015824) |
0.0 | 0.6 | GO:0033047 | regulation of mitotic sister chromatid segregation(GO:0033047) |
0.0 | 0.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.0 | 0.1 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 0.1 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.1 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.0 | 0.1 | GO:1990564 | protein ufmylation(GO:0071569) protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
0.0 | 0.1 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.0 | 0.5 | GO:0036257 | multivesicular body organization(GO:0036257) |
0.0 | 0.4 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.0 | 0.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.1 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.2 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.0 | 1.9 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.1 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.0 | 1.1 | GO:0016575 | histone deacetylation(GO:0016575) |
0.0 | 0.1 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.0 | 0.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.1 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.2 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.1 | GO:0021759 | globus pallidus development(GO:0021759) |
0.0 | 0.1 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.0 | 0.1 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.0 | 0.3 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.1 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.0 | 0.2 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 0.1 | GO:0015866 | ADP transport(GO:0015866) ATP transport(GO:0015867) |
0.0 | 0.2 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.0 | GO:0032479 | regulation of type I interferon production(GO:0032479) |
0.0 | 0.1 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.1 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.4 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.0 | 0.0 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
0.0 | 0.1 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.0 | 0.0 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.0 | 0.4 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.0 | 0.1 | GO:0046512 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.0 | 0.1 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
0.0 | 1.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.1 | GO:0006692 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.0 | 0.0 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.0 | 0.1 | GO:0042262 | DNA protection(GO:0042262) |
0.0 | 0.4 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.1 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.2 | GO:0006754 | ATP biosynthetic process(GO:0006754) |
0.0 | 0.1 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:0000002 | mitochondrial genome maintenance(GO:0000002) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.1 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
0.0 | 0.2 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.0 | 0.0 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.2 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.0 | 0.0 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.0 | 0.0 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.0 | 0.8 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.3 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.1 | GO:0001696 | gastric acid secretion(GO:0001696) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.1 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.1 | GO:0046427 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.0 | 0.1 | GO:0051056 | regulation of small GTPase mediated signal transduction(GO:0051056) |
0.0 | 0.1 | GO:1903874 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 16.4 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
1.2 | 3.5 | GO:0097679 | other organism cytoplasm(GO:0097679) |
1.1 | 3.4 | GO:0030526 | granulocyte macrophage colony-stimulating factor receptor complex(GO:0030526) |
1.1 | 14.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
1.0 | 3.1 | GO:0032997 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
1.0 | 5.2 | GO:0036398 | TCR signalosome(GO:0036398) |
1.0 | 10.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.9 | 0.9 | GO:0097179 | protease inhibitor complex(GO:0097179) |
0.9 | 7.5 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.9 | 18.1 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.9 | 2.6 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.8 | 5.8 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.8 | 2.5 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.8 | 19.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.8 | 4.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.7 | 0.7 | GO:0032589 | neuron projection membrane(GO:0032589) |
0.7 | 5.1 | GO:0044194 | cytolytic granule(GO:0044194) |
0.6 | 2.4 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
0.6 | 5.8 | GO:0032010 | phagolysosome(GO:0032010) |
0.5 | 10.0 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.5 | 0.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.5 | 18.2 | GO:0001891 | phagocytic cup(GO:0001891) |
0.5 | 5.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 1.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.5 | 1.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.5 | 4.2 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
0.5 | 1.8 | GO:0044753 | amphisome(GO:0044753) |
0.4 | 2.2 | GO:0031430 | M band(GO:0031430) |
0.4 | 7.9 | GO:0071439 | clathrin complex(GO:0071439) |
0.4 | 2.5 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.4 | 2.9 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.4 | 9.8 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 12.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.4 | 3.0 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
0.4 | 2.2 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.4 | 4.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.4 | 1.1 | GO:0097447 | dendritic tree(GO:0097447) |
0.4 | 0.7 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.4 | 1.8 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
0.3 | 1.4 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.3 | 0.7 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.3 | 2.0 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.3 | 0.7 | GO:0030055 | focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
0.3 | 17.8 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.3 | 5.3 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 1.8 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
0.3 | 3.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 1.5 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.3 | 3.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 3.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.3 | 2.0 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.3 | 15.1 | GO:0001772 | immunological synapse(GO:0001772) |
0.3 | 2.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.3 | 0.3 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
0.3 | 1.4 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 2.8 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.3 | 31.4 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.3 | 3.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.3 | 11.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 0.8 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.3 | 1.6 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.3 | 1.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.3 | 1.3 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
0.3 | 1.8 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.3 | 2.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.3 | 1.0 | GO:0031592 | centrosomal corona(GO:0031592) |
0.3 | 1.3 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 2.0 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 0.8 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.3 | 0.8 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.2 | 1.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 1.0 | GO:1902912 | pyruvate kinase complex(GO:1902912) |
0.2 | 11.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.2 | 7.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 80.3 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.2 | 8.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 42.7 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.7 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.2 | 2.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.2 | 22.1 | GO:0035580 | specific granule lumen(GO:0035580) |
0.2 | 1.1 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.2 | 0.2 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.2 | 0.7 | GO:0098844 | postsynaptic endocytic zone membrane(GO:0098844) |
0.2 | 0.4 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.2 | 6.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.7 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.2 | 0.7 | GO:0075341 | host cell PML body(GO:0075341) |
0.2 | 52.1 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.2 | 3.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.2 | 0.6 | GO:0034515 | proteasome storage granule(GO:0034515) |
0.2 | 2.9 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 2.7 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.8 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.2 | 19.2 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.2 | 0.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 0.6 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.2 | 1.0 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.2 | 3.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 1.4 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 4.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.2 | 1.0 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.2 | 2.1 | GO:0098560 | cytoplasmic side of late endosome membrane(GO:0098560) |
0.2 | 3.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 0.9 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 0.4 | GO:0097433 | dense body(GO:0097433) |
0.2 | 3.2 | GO:0036020 | endolysosome membrane(GO:0036020) |
0.2 | 4.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.2 | 2.7 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.2 | 0.7 | GO:0043291 | RAVE complex(GO:0043291) |
0.2 | 1.4 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.2 | 2.5 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.3 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.2 | 0.5 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.2 | 0.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
0.2 | 0.4 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.2 | 0.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.2 | 1.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 0.9 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.2 | 0.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.2 | 0.7 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.3 | GO:0001740 | Barr body(GO:0001740) |
0.2 | 1.8 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.2 | 6.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 3.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.2 | 1.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.2 | 1.2 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.6 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
0.2 | 0.9 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
0.2 | 2.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 1.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.2 | 0.9 | GO:1990037 | Lewy body core(GO:1990037) |
0.2 | 0.8 | GO:0098805 | whole membrane(GO:0098805) |
0.2 | 0.9 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 2.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.1 | 2.2 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 16.3 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 1.7 | GO:0044754 | autolysosome(GO:0044754) |
0.1 | 0.4 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 15.9 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.1 | 0.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.1 | 2.1 | GO:0070938 | contractile ring(GO:0070938) |
0.1 | 0.7 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 6.6 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 1.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.1 | 21.9 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.1 | 1.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.3 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 1.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 0.3 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.5 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.1 | 1.6 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.7 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.1 | 1.4 | GO:0097486 | multivesicular body lumen(GO:0097486) |
0.1 | 1.7 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
0.1 | 2.1 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 3.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.9 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 6.0 | GO:0090544 | BAF-type complex(GO:0090544) |
0.1 | 1.2 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.5 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.8 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.7 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.1 | 0.1 | GO:0098794 | postsynapse(GO:0098794) |
0.1 | 1.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.5 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 1.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 14.0 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.4 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.1 | 0.5 | GO:0014802 | terminal cisterna(GO:0014802) |
0.1 | 0.9 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 1.7 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 0.8 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
0.1 | 2.0 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 2.0 | GO:0005861 | troponin complex(GO:0005861) |
0.1 | 1.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 1.6 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.1 | 2.4 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.4 | GO:0097196 | Shu complex(GO:0097196) |
0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 1.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.6 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.1 | 0.5 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.4 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.4 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 2.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.6 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 1.2 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.1 | 0.3 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 1.7 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 0.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.1 | 0.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 4.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 1.2 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 0.3 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.1 | 1.0 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 1.2 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 3.0 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.6 | GO:1990246 | uniplex complex(GO:1990246) |
0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 1.7 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 1.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.4 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.1 | 0.3 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.1 | 0.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.1 | 0.9 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 2.7 | GO:0031011 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.1 | 0.4 | GO:0097452 | GAIT complex(GO:0097452) |
0.1 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.1 | 0.3 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.1 | 1.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 0.6 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.1 | 0.9 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.4 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.1 | 4.1 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.1 | 3.2 | GO:0031105 | septin complex(GO:0031105) |
0.1 | 1.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 1.4 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.1 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.1 | 1.3 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 0.8 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.7 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.1 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.1 | 0.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.2 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.1 | 0.5 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.1 | 1.0 | GO:0045275 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 0.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 2.2 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.9 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 1.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 0.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 1.3 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.1 | 0.3 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 1.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.4 | GO:0030904 | retromer complex(GO:0030904) |
0.1 | 0.6 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 8.3 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 0.6 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.4 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.5 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.4 | GO:0035370 | UBC13-UEV1A complex(GO:0035370) |
0.1 | 0.4 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 0.6 | GO:0061617 | MICOS complex(GO:0061617) |
0.1 | 4.3 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.3 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 0.2 | GO:0030689 | Noc complex(GO:0030689) |
0.1 | 6.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.1 | 1.6 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.1 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.5 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.7 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.5 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 1.2 | GO:0038201 | TOR complex(GO:0038201) |
0.1 | 2.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.1 | 0.6 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.6 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 6.7 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.1 | 0.7 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.3 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.4 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.1 | 0.1 | GO:0097422 | tubular endosome(GO:0097422) |
0.1 | 1.3 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 15.2 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.1 | 6.3 | GO:0098552 | side of membrane(GO:0098552) |
0.1 | 0.4 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.1 | 0.4 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.1 | 0.8 | GO:0000124 | SAGA complex(GO:0000124) |
0.1 | 3.6 | GO:0009295 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.1 | 0.4 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 2.5 | GO:0097228 | sperm principal piece(GO:0097228) |
0.1 | 0.5 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
0.1 | 0.1 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 0.2 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.1 | 8.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.1 | 0.4 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.1 | 0.1 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 0.9 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.3 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.1 | 5.2 | GO:0034704 | calcium channel complex(GO:0034704) |
0.1 | 3.9 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.9 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.5 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.1 | 1.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.4 | GO:0031305 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 1.3 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.0 | GO:0005845 | mRNA cap binding complex(GO:0005845) |
0.1 | 0.8 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.9 | GO:0005763 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 0.1 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 0.7 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 1.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 1.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 1.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 6.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.4 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.2 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
0.0 | 5.6 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.7 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.0 | 1.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 1.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 2.2 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.4 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.0 | 1.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.3 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.8 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.5 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.0 | 0.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.0 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 1.5 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.0 | 0.6 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.3 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
0.0 | 0.2 | GO:0002133 | polycystin complex(GO:0002133) |
0.0 | 2.5 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.0 | 0.5 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 2.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.0 | 0.4 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 1.6 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 0.3 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.0 | 20.4 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 3.0 | GO:0000790 | nuclear chromatin(GO:0000790) |
0.0 | 1.2 | GO:0031300 | intrinsic component of organelle membrane(GO:0031300) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 2.9 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.8 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.0 | 16.7 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.1 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.7 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 0.3 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.3 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.2 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
0.0 | 0.1 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.0 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.1 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.0 | 1.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.6 | GO:0030532 | small nuclear ribonucleoprotein complex(GO:0030532) |
0.0 | 0.2 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 0.2 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 0.2 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 3.2 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 9.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 1.0 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.0 | 0.1 | GO:0036338 | viral envelope(GO:0019031) viral membrane(GO:0036338) |
0.0 | 0.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.0 | 2.5 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.3 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 0.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.4 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 1.5 | GO:0044391 | ribosomal subunit(GO:0044391) |
0.0 | 0.1 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.1 | GO:0019034 | viral replication complex(GO:0019034) host cell nuclear part(GO:0044094) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.1 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.4 | GO:0030686 | 90S preribosome(GO:0030686) |
0.0 | 0.3 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.2 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.0 | 1.9 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.0 | 0.2 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.0 | 6.5 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.1 | GO:0048500 | signal recognition particle(GO:0048500) |
0.0 | 0.2 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.0 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
0.0 | 1.2 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.0 | 2.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.2 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 1.9 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.2 | GO:0033010 | paranodal junction(GO:0033010) |
0.0 | 3.6 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 1.2 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.0 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.0 | 0.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.1 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.6 | GO:0031902 | late endosome membrane(GO:0031902) |
0.0 | 0.6 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.6 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
0.0 | 0.1 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.0 | 0.0 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 0.9 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.8 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
0.0 | 1.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.0 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.8 | GO:0005174 | CD40 receptor binding(GO:0005174) |
2.1 | 4.2 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
2.0 | 12.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
1.6 | 4.8 | GO:0004108 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
1.6 | 6.2 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
1.5 | 5.9 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
1.3 | 15.5 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
1.1 | 4.6 | GO:0032396 | inhibitory MHC class I receptor activity(GO:0032396) |
1.0 | 3.0 | GO:0004676 | 3-phosphoinositide-dependent protein kinase activity(GO:0004676) |
1.0 | 3.0 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
1.0 | 3.9 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.9 | 2.7 | GO:0004397 | histidine ammonia-lyase activity(GO:0004397) |
0.9 | 4.4 | GO:0015254 | glycerol channel activity(GO:0015254) |
0.9 | 2.6 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.8 | 6.8 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.8 | 10.1 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.8 | 2.5 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.8 | 2.4 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
0.8 | 3.9 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.8 | 6.9 | GO:0042610 | CD8 receptor binding(GO:0042610) |
0.7 | 2.2 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.7 | 2.2 | GO:0019976 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
0.7 | 3.0 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
0.7 | 2.2 | GO:0031768 | ghrelin receptor binding(GO:0031768) |
0.7 | 5.1 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.7 | 4.9 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.7 | 3.5 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.7 | 12.9 | GO:0019864 | IgG binding(GO:0019864) |
0.7 | 2.0 | GO:0016495 | C-X3-C chemokine receptor activity(GO:0016495) |
0.6 | 4.4 | GO:0042806 | fucose binding(GO:0042806) |
0.6 | 2.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.6 | 1.8 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.6 | 4.1 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.6 | 0.6 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
0.6 | 4.0 | GO:0034988 | Fc-gamma receptor I complex binding(GO:0034988) |
0.6 | 2.3 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.6 | 2.3 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.6 | 2.2 | GO:0034647 | histone demethylase activity (H3-trimethyl-K4 specific)(GO:0034647) |
0.6 | 2.2 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.6 | 5.6 | GO:0030883 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.6 | 6.1 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.6 | 9.4 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.6 | 20.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.6 | 6.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.5 | 3.3 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.5 | 2.2 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.5 | 2.1 | GO:0030305 | beta-glucuronidase activity(GO:0004566) heparanase activity(GO:0030305) |
0.5 | 2.1 | GO:0048030 | disaccharide binding(GO:0048030) |
0.5 | 4.5 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.5 | 2.5 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.5 | 1.5 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
0.5 | 2.9 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 2.8 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.5 | 2.3 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
0.5 | 9.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.5 | 2.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.5 | 2.3 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
0.5 | 7.3 | GO:0042287 | MHC protein binding(GO:0042287) |
0.5 | 5.0 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.5 | 2.3 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
0.4 | 1.3 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.4 | 1.3 | GO:0050135 | NAD(P)+ nucleosidase activity(GO:0050135) |
0.4 | 12.9 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.4 | 9.5 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.4 | 1.6 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.4 | 2.4 | GO:0004918 | interleukin-8 receptor activity(GO:0004918) |
0.4 | 6.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.4 | 2.0 | GO:0005011 | macrophage colony-stimulating factor receptor activity(GO:0005011) |
0.4 | 4.0 | GO:0038049 | transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) |
0.4 | 2.4 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.4 | 2.0 | GO:0033265 | choline binding(GO:0033265) |
0.4 | 0.8 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.4 | 1.2 | GO:0008859 | exoribonuclease II activity(GO:0008859) |
0.4 | 2.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.4 | 7.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.4 | 4.8 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.4 | 1.9 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.4 | 4.4 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.4 | 1.8 | GO:1990450 | linear polyubiquitin binding(GO:1990450) |
0.4 | 1.4 | GO:0005459 | UDP-galactose transmembrane transporter activity(GO:0005459) |
0.4 | 21.0 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.4 | 2.5 | GO:0070728 | leucine binding(GO:0070728) |
0.4 | 2.2 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.4 | 1.8 | GO:0016623 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.4 | 5.4 | GO:0033691 | sialic acid binding(GO:0033691) |
0.4 | 3.6 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.4 | 3.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.4 | 1.1 | GO:0031896 | V2 vasopressin receptor binding(GO:0031896) |
0.3 | 3.1 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.3 | 0.3 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.3 | 6.1 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.3 | 1.7 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.3 | 1.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 1.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 1.3 | GO:0004802 | transketolase activity(GO:0004802) |
0.3 | 1.9 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 8.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.3 | 2.9 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 2.5 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.3 | 2.5 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.3 | 1.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 2.8 | GO:0019863 | IgE binding(GO:0019863) |
0.3 | 54.8 | GO:0003823 | antigen binding(GO:0003823) |
0.3 | 5.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.3 | 1.8 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.3 | 0.9 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 0.9 | GO:0052894 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.3 | 4.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.3 | 2.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.3 | 1.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.3 | 6.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.3 | 7.4 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.8 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 1.2 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
0.3 | 7.3 | GO:0050700 | CARD domain binding(GO:0050700) |
0.3 | 0.9 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
0.3 | 1.7 | GO:0039552 | RIG-I binding(GO:0039552) |
0.3 | 2.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.3 | 5.1 | GO:0003680 | AT DNA binding(GO:0003680) |
0.3 | 2.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.3 | 1.4 | GO:0010736 | serum response element binding(GO:0010736) |
0.3 | 26.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 1.7 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.3 | 2.3 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.3 | 3.7 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 1.1 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
0.3 | 3.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 0.8 | GO:0071077 | coenzyme A transmembrane transporter activity(GO:0015228) adenosine 3',5'-bisphosphate transmembrane transporter activity(GO:0071077) AMP transmembrane transporter activity(GO:0080122) |
0.3 | 1.4 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.3 | 1.4 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
0.3 | 2.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.3 | 2.4 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.3 | 1.9 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.3 | 1.1 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.3 | 0.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.3 | 1.9 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 0.8 | GO:0019778 | Atg12 activating enzyme activity(GO:0019778) Atg8 activating enzyme activity(GO:0019779) |
0.3 | 1.1 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.3 | 1.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.3 | 2.6 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.3 | 1.0 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.3 | 1.0 | GO:0047860 | diiodophenylpyruvate reductase activity(GO:0047860) |
0.3 | 2.1 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.3 | 1.3 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.3 | 1.8 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.3 | 2.3 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 1.0 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.3 | 0.8 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
0.2 | 0.7 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.2 | 5.7 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 1.0 | GO:0030343 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.2 | 1.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.2 | 1.0 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.2 | 1.0 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.2 | 0.2 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.2 | 0.7 | GO:0050333 | thiamin-triphosphatase activity(GO:0050333) |
0.2 | 10.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 0.5 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.2 | 0.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.2 | 3.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.6 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
0.2 | 0.7 | GO:0000224 | peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity(GO:0000224) |
0.2 | 0.9 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 0.7 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.2 | 1.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.2 | 0.9 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.2 | 7.3 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 0.7 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.2 | 11.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 3.8 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.2 | 8.6 | GO:0019198 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.2 | 1.5 | GO:0097199 | cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097199) |
0.2 | 5.5 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 1.7 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.2 | 0.9 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.2 | 0.6 | GO:0004483 | mRNA (nucleoside-2'-O-)-methyltransferase activity(GO:0004483) |
0.2 | 2.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.2 | 1.9 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.2 | 2.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 2.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.2 | 5.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.2 | 2.1 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.2 | 0.8 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.2 | 1.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 1.7 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 6.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
0.2 | 0.8 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 5.7 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.2 | 1.0 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.2 | 1.8 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.2 | 1.6 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
0.2 | 0.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.2 | 1.0 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.2 | 0.8 | GO:0016901 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
0.2 | 3.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.6 | GO:0036313 | phosphatidylinositol 3-kinase catalytic subunit binding(GO:0036313) |
0.2 | 3.9 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 0.8 | GO:0016263 | glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity(GO:0016263) |
0.2 | 0.4 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.2 | 0.2 | GO:0043121 | neurotrophin binding(GO:0043121) brain-derived neurotrophic factor binding(GO:0048403) |
0.2 | 1.7 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 1.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 5.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 0.8 | GO:0034648 | histone demethylase activity (H3-dimethyl-K4 specific)(GO:0034648) |
0.2 | 0.9 | GO:0035473 | lipase binding(GO:0035473) |
0.2 | 3.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.1 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.2 | 0.4 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
0.2 | 5.3 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 0.9 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.2 | 0.2 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
0.2 | 1.1 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.2 | 6.4 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 1.6 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.2 | 0.2 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.2 | 0.5 | GO:0042356 | GDP-4-dehydro-D-rhamnose reductase activity(GO:0042356) GDP-L-fucose synthase activity(GO:0050577) |
0.2 | 0.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.2 | 0.9 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.2 | 0.5 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.2 | 0.7 | GO:0051734 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.2 | 3.9 | GO:0005522 | profilin binding(GO:0005522) |
0.2 | 1.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 2.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.2 | 1.0 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.2 | 0.9 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.2 | 0.7 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.2 | 0.7 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.2 | 0.9 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 7.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.2 | 2.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.2 | 1.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 2.5 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 1.2 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.5 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.2 | 1.7 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.2 | 0.2 | GO:0015926 | glucosidase activity(GO:0015926) |
0.2 | 1.3 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.2 | 0.8 | GO:0004556 | alpha-amylase activity(GO:0004556) |
0.2 | 0.5 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.2 | 5.5 | GO:0031489 | myosin V binding(GO:0031489) |
0.2 | 0.8 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.5 | GO:0097689 | iron channel activity(GO:0097689) |
0.2 | 0.8 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.2 | 0.5 | GO:0016749 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
0.2 | 7.2 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.2 | 0.5 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.2 | 0.5 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.2 | 2.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.2 | 3.6 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.2 | 1.2 | GO:0016728 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 4.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.2 | 0.8 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.2 | 0.5 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.2 | 2.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.2 | 3.3 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.2 | 0.6 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.2 | 2.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 0.5 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.1 | 2.8 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.0 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 1.3 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.6 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 1.0 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 2.7 | GO:0001163 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.1 | 0.7 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 5.0 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
0.1 | 1.3 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 2.7 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
0.1 | 10.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.1 | 4.7 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 3.2 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.4 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.4 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
0.1 | 0.7 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.1 | 0.7 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 1.2 | GO:0042835 | BRE binding(GO:0042835) |
0.1 | 0.8 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.1 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.5 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.1 | 0.4 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.4 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.1 | 4.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.1 | 0.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 1.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 1.9 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.3 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
0.1 | 6.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.1 | 0.9 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.1 | 0.9 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.1 | 0.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.1 | 3.9 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 1.8 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 2.1 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 0.4 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.1 | 6.6 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 3.0 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.4 | GO:0086040 | sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086040) |
0.1 | 1.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 1.4 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 1.0 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 1.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.5 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.1 | 0.5 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.1 | 2.9 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.1 | 3.1 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 0.5 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
0.1 | 0.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 9.2 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.4 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.1 | 1.7 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) |
0.1 | 1.6 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.1 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.1 | 3.0 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.4 | GO:0004968 | gonadotropin-releasing hormone receptor activity(GO:0004968) |
0.1 | 0.4 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.1 | 0.6 | GO:0098626 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
0.1 | 0.4 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.1 | 1.1 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.5 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.1 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
0.1 | 0.5 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 4.5 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.1 | 1.4 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.5 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.6 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.1 | 0.3 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.1 | 1.5 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 1.9 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.1 | 1.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.3 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.1 | 1.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.4 | GO:0004452 | isopentenyl-diphosphate delta-isomerase activity(GO:0004452) |
0.1 | 0.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.1 | 0.7 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 0.6 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.4 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
0.1 | 0.6 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.8 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.4 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 3.4 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.4 | GO:0016426 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 8.5 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.1 | 0.3 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.1 | 1.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.6 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.3 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.1 | 0.6 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
0.1 | 1.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.1 | 0.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 0.8 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 6.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.0 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.8 | GO:0030021 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.3 | GO:0005230 | extracellular ligand-gated ion channel activity(GO:0005230) |
0.1 | 0.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.1 | 1.0 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 0.5 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.9 | GO:0031013 | troponin I binding(GO:0031013) |
0.1 | 1.5 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.9 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 0.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.1 | 1.4 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 1.4 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 3.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 1.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.8 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.1 | 0.9 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.6 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 2.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.1 | 0.5 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 1.2 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 4.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.1 | 0.8 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 1.0 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.3 | GO:0004421 | hydroxymethylglutaryl-CoA synthase activity(GO:0004421) |
0.1 | 2.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.1 | 0.4 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 1.0 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 1.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.4 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 7.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 1.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.9 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 1.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 2.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 0.6 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.3 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.1 | 7.6 | GO:0016279 | protein-lysine N-methyltransferase activity(GO:0016279) |
0.1 | 1.0 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 1.3 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.5 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.5 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.1 | 1.6 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0048040 | UDP-glucuronate decarboxylase activity(GO:0048040) |
0.1 | 0.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.3 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.1 | 0.6 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.1 | 1.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.5 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 3.6 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 2.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.1 | 0.6 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.1 | 0.7 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 2.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.1 | 0.6 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 6.9 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.1 | 2.1 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.3 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.1 | 0.2 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
0.1 | 0.1 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.1 | 1.4 | GO:0000150 | recombinase activity(GO:0000150) |
0.1 | 4.6 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.1 | 0.5 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.1 | 1.1 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 0.5 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.1 | 0.5 | GO:0019237 | centromeric DNA binding(GO:0019237) |
0.1 | 1.7 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 3.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.3 | GO:0032183 | SUMO binding(GO:0032183) |
0.1 | 0.5 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.1 | 0.5 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.7 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 2.7 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 0.5 | GO:0030276 | clathrin binding(GO:0030276) |
0.1 | 0.3 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.2 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.1 | 0.2 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.1 | 0.1 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.1 | 2.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
0.1 | 0.1 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 1.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.1 | 0.5 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.1 | 0.8 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.1 | 0.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.1 | 0.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 4.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.1 | 0.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.1 | 0.5 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.1 | 0.3 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 1.7 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 2.5 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.1 | 0.8 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 1.3 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 3.7 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.1 | 0.3 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
0.1 | 1.0 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.2 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.1 | 1.5 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.2 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.1 | 0.6 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.1 | 0.6 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.1 | 0.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.1 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.1 | 0.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.7 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.2 | GO:0070546 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.1 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 0.3 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.1 | 0.7 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.1 | 1.0 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.1 | 16.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 0.3 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 3.6 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 1.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.1 | 0.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.1 | 1.9 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 0.3 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.1 | 0.9 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.3 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 6.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.4 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.1 | 0.2 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
0.1 | 0.4 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 0.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.1 | 1.1 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.3 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.1 | 1.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.1 | GO:1904854 | proteasome core complex binding(GO:1904854) |
0.1 | 0.3 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.1 | 1.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 1.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.3 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.5 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.1 | 0.5 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 5.5 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 0.2 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.1 | 1.2 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 0.4 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.2 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.1 | 0.1 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.1 | 0.2 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) RNA polymerase III type 3 promoter DNA binding(GO:0001032) TFIIIC-class transcription factor binding(GO:0001156) |
0.1 | 0.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.8 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.3 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.1 | 0.6 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 3.8 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.5 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 0.2 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 1.2 | GO:0032452 | histone demethylase activity(GO:0032452) |
0.1 | 0.5 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 0.9 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 1.7 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.1 | 0.2 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 0.2 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 3.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.4 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.1 | 0.5 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.5 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.1 | 1.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 2.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 22.0 | GO:0030695 | GTPase regulator activity(GO:0030695) |
0.0 | 0.6 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.0 | 2.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.0 | 0.9 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.2 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.0 | 0.5 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 1.0 | GO:0005536 | glucose binding(GO:0005536) |
0.0 | 1.8 | GO:0070888 | E-box binding(GO:0070888) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.2 | GO:0050308 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
0.0 | 0.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.0 | 0.3 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.0 | 0.2 | GO:0043734 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.0 | 3.1 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 0.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.8 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.0 | 0.4 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.0 | 0.5 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.0 | 1.0 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.8 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.2 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.0 | 0.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.0 | 0.2 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.0 | 0.1 | GO:0008398 | sterol 14-demethylase activity(GO:0008398) |
0.0 | 2.1 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.4 | GO:0004950 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.0 | 0.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 3.2 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.4 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.1 | GO:0008478 | pyridoxal kinase activity(GO:0008478) |
0.0 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) 3'-flap endonuclease activity(GO:0048257) |
0.0 | 0.4 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 1.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.2 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.0 | 0.3 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.2 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.0 | 0.2 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.0 | 3.7 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.0 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.0 | 0.1 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.0 | 0.4 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 0.6 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.1 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.0 | 4.5 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.2 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.0 | 0.3 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.0 | 0.6 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 1.7 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.5 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 1.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.0 | 0.8 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.0 | 9.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 1.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.0 | 1.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.0 | 0.1 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.0 | 0.1 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.0 | 0.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.5 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.1 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.0 | 0.2 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.2 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:0005457 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
0.0 | 13.1 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 1.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.0 | 0.8 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.1 | GO:0061598 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.0 | 0.2 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.0 | 0.1 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 1.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.0 | 0.5 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.1 | GO:0016725 | oxidoreductase activity, acting on CH or CH2 groups(GO:0016725) |
0.0 | 0.1 | GO:0047017 | geranylgeranyl reductase activity(GO:0045550) prostaglandin-F synthase activity(GO:0047017) |
0.0 | 0.2 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.1 | GO:0070984 | SET domain binding(GO:0070984) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 0.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
0.0 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
0.0 | 0.1 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.0 | 8.8 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 1.8 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 3.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.3 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.0 | 0.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.4 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 0.2 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.3 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.1 | GO:0004492 | methylmalonyl-CoA decarboxylase activity(GO:0004492) |
0.0 | 0.6 | GO:0004672 | protein kinase activity(GO:0004672) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.0 | 0.1 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.0 | 0.3 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.1 | GO:0043813 | phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity(GO:0043813) |
0.0 | 2.7 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) |
0.0 | 13.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 2.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.8 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) L-proline transmembrane transporter activity(GO:0015193) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.0 | 0.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.0 | 0.1 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 0.4 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.1 | GO:0089720 | caspase binding(GO:0089720) |
0.0 | 0.1 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.0 | 0.1 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
0.0 | 0.2 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
0.0 | 1.6 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.0 | 0.5 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.0 | 0.1 | GO:0032810 | sterol response element binding(GO:0032810) |
0.0 | 0.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.2 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.0 | 1.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:1903136 | cuprous ion binding(GO:1903136) |
0.0 | 0.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.0 | 0.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.0 | 0.1 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.0 | 0.5 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.2 | GO:0005314 | high-affinity glutamate transmembrane transporter activity(GO:0005314) |
0.0 | 0.1 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.0 | 0.1 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.0 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.0 | 0.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.0 | 0.1 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.0 | 0.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.1 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.0 | 0.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.3 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 0.1 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.0 | 0.1 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 0.1 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
0.0 | 0.1 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.0 | 0.1 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.0 | 0.1 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.0 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.8 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.0 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.0 | 0.0 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.0 | 0.1 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 1.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.2 | GO:0017022 | myosin binding(GO:0017022) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 71.3 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.6 | 21.5 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.5 | 36.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.4 | 16.0 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.4 | 1.8 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.3 | 18.2 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 0.3 | PID ERBB1 RECEPTOR PROXIMAL PATHWAY | EGF receptor (ErbB1) signaling pathway |
0.3 | 8.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.3 | 11.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.3 | 3.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.3 | 11.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.3 | 16.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.3 | 21.8 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 10.1 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.2 | 2.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 10.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 3.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.2 | 2.8 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.2 | 7.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 9.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.2 | 5.9 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 5.5 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 5.5 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 0.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.2 | 0.6 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 12.8 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.1 | 5.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 4.9 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.1 | 4.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 5.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 6.4 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.1 | 4.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 3.8 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.1 | 6.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 13.3 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 14.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 1.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 3.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 4.3 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.1 | 3.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 7.6 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.0 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 1.6 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 2.8 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 1.6 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 1.0 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 3.5 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.1 | 7.5 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 3.7 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 2.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.6 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.1 | 8.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 1.1 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.1 | 8.0 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 3.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.6 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 3.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 3.4 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.7 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 2.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.2 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 5.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.9 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 3.5 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 8.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 4.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 4.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 2.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 0.6 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 0.6 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.1 | 1.0 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.1 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 1.3 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 1.7 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.9 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 2.8 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 2.3 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 5.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 1.2 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 5.5 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 1.3 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 2.4 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 2.2 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 2.1 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 1.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.8 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.5 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.6 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.0 | 2.1 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.2 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.0 | 0.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.6 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.6 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.0 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.4 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.0 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.5 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.5 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 26.7 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.9 | 7.0 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.7 | 82.9 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.6 | 5.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.5 | 16.7 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.5 | 4.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.5 | 12.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 4.2 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.4 | 2.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 5.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.4 | 11.8 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 9.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.4 | 7.7 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 18.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.3 | 4.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.3 | 2.0 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.3 | 31.8 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.3 | 9.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.3 | 3.8 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.3 | 0.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 0.3 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 3.9 | REACTOME IL 2 SIGNALING | Genes involved in Interleukin-2 signaling |
0.3 | 11.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.3 | 6.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 9.8 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.3 | 3.6 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.3 | 8.0 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.2 | 4.9 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.2 | 7.8 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.2 | 9.1 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.2 | 13.6 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.2 | 0.9 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.2 | 4.3 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.2 | 2.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.2 | 15.0 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.2 | 3.5 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.2 | 5.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.2 | 0.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.2 | 3.4 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.2 | 6.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.2 | 6.9 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.2 | 10.9 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 10.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.2 | 0.7 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 5.0 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.2 | 19.9 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.2 | 13.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 3.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 2.5 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.2 | 0.6 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.1 | 8.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 4.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 5.6 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.1 | 3.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.1 | 3.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 3.5 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.1 | 4.9 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 2.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 0.7 | REACTOME S PHASE | Genes involved in S Phase |
0.1 | 0.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 3.4 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 1.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 5.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 6.2 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
0.1 | 1.8 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.1 | 3.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 1.3 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.1 | 1.4 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.1 | 2.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 5.2 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.1 | 6.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.1 | 14.3 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 2.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.5 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 3.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 1.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.1 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.8 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.1 | 2.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.7 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 8.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 12.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.1 | 6.8 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 8.8 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 1.8 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.1 | 1.9 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 3.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.1 | 1.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 0.3 | REACTOME SIGNALING BY ILS | Genes involved in Signaling by Interleukins |
0.1 | 2.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.1 | 0.6 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.3 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.6 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.1 | 3.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 0.6 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.1 | 2.6 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.1 | 1.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 0.5 | REACTOME GAB1 SIGNALOSOME | Genes involved in GAB1 signalosome |
0.1 | 1.2 | REACTOME TELOMERE MAINTENANCE | Genes involved in Telomere Maintenance |
0.1 | 1.8 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 2.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 3.2 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.1 | 1.9 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.0 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.1 | 2.9 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.1 | 8.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 2.2 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.8 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 0.2 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.1 | REACTOME ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | Genes involved in Activation of NMDA receptor upon glutamate binding and postsynaptic events |
0.1 | 0.3 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.1 | 1.9 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.1 | 2.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.0 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 2.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.1 | 1.3 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.0 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.6 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 1.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 3.2 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.4 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.1 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.1 | 0.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.1 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.4 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 1.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.3 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.1 | 8.9 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 1.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.6 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 5.0 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.2 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 1.3 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 1.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 11.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 7.8 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.0 | 1.6 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 2.2 | REACTOME TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM | Genes involved in Transport of Mature Transcript to Cytoplasm |
0.0 | 0.9 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 1.7 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.0 | 2.5 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 2.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 2.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 7.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
0.0 | 0.5 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 2.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 0.3 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 8.6 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.4 | REACTOME REGULATION OF ORNITHINE DECARBOXYLASE ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
0.0 | 0.4 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 2.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.4 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.0 | 0.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.0 | 1.0 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.7 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.0 | 0.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 1.2 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 1.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
0.0 | 2.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.5 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
0.0 | 0.7 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 0.6 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.2 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.2 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.0 | 2.1 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.3 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.0 | 0.7 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.6 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.7 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.5 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.0 | 1.6 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 1.9 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 3.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.6 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.0 | 0.0 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.0 | 0.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.0 | 0.5 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.0 | 0.3 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |